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Abstract 
 
This systematic review compared the efficacy and safety of ephedrine with phenylephrine 
for the treatment of hypotension during spinal anesthesia for cesarean delivery. 
Hypotension during cesarean section delivery can have detrimental effects on both the 
mother and the neonate. Some vasoactive medications such as ephedrine and 
phenylephrine have been found to be detrimental to the neonate and divert fetal blood 
flow. After a systematic search of the electronic database PubMed, the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart was 
used to identify appropriate research. Studies were illustrated in a table to identify key 
variables and were then critically appraised. Outcomes included oxygen supplementation 
use, ASA classification, IV fluid prehydration, hypotension incidence after spinal 
anesthesia, spinal solution and technique, umbilical artery pH, Apgar scores, and nausea 
and vomiting during the case.  Findings revealed no difference in the use of oxygen 
supplementation, ASA classification, IV fluid prehydration, spinal solution or technique 
on fetal umbilical artery pH.   Women given phenylephrine had neonates with higher 
umbilical artery pH values than those given ephedrine but there was no significant 
difference between the two vasopressors in the incidence of true fetal acidosis (umbilical 
artery pH < 7.20 or Apgar <7 at 1 and 5 min). There was an incidental finding from two 
studies that additionally examined nausea and vomiting that there was an increase 
occurrence of nausea and vomiting with ephedrine administration as compared to 
phenylephrine administration. This systematic review supports the view that ephedrine 
and phenylephrine have equal efficacy and safety when administered to obstetric patients 
experiencing hypotension after spinal anesthesia during cesarean sections.  
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A Systematic Review Comparing Ephedrine versus Phenylephrine during Spinal 
Anesthesia for Cesarean Delivery 
Background/Statement of the Problem 
              Hypotension during spinal anesthesia for elective caesarean delivery occurs in 
about 70-80% of cases (Mercier, Augè, Hoffmann, Fischer & Le Gouez, 2013) and may 
have detrimental effects on both the mother and the neonate (lee, Kee & Gin 2002). 
These effects include decreased uteroplacental blood flow, impaired fetal oxygenation 
with asphyxial stress and fetal acidosis (Lee et al., 2002). Associated effects include 
maternal symptoms of low cardiac output such as dizziness and decreased consciousness, 
usually requiring vasoactive drugs as treatment (Lee et al.). Some vasoactive medications 
have been found to be detrimental to the neonate and divert fetal blood flow, potentially 
causing more harm than good in pregnant women (Nagelhout, Elisha & Plaus, 2013). 
Ephedrine and phenylephrine are two vasoactive drugs that reportedly do not change the 
blood flow to the fetus and therefore are drugs of choice in obstetric patients (Nagelhout 
et al.). An important clinical question is which vasoactive drug is best for these patients?            
             Studies have shown that ephedrine can cause fetal acidosis as a side effect and 
more so than phenylephrine; concerns about the adverse effects of phenylephrine on 
uterine blood flow have also been reported (Nagelhout et al., 2013).  Ephedrine is a 
mixed acting adrenergic receptor agonist that has both alpha and beta agonist properties 
(Nagelhout et al.). Ephedrine’s predominant beta effect causes an increase in arterial 
pressure by increasing cardiac output rather than by vasoconstriction (Nagelhout et al.). 
Phenylephrine is a pure alpha-adrenergic agonist which increases the blood pressure 
through peripheral vasoconstriction (Nagelhout et al.).  A literature review of vasoactive 
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drugs conducted on animals varies in terms of the safety and efficacy of the two drugs. 
The results may not apply to the human populations and may not be appropriate because 
of the species differences (Lee et al., 2002).   
             The purpose of this paper was to conduct a systematic review to compare the 
safety and efficacy of the use of ephedrine versus phenylephrine in managing maternal 
hypotension during spinal anesthesia for cesarean delivery. The effect of ephedrine and 
phenylephrine on uteroplacental blood flow and fetal outcome will be specifically 
examined.  
             Next, the review of the literature will be presented. 
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Literature Review 
 
A search was conducted using PubMed.  Key terms searched were cesarean 
delivery, cesarean delivery complications, spinal anesthesia, hypotension, maternal 
hypotension, ephedrine, phenylephrine, vasoactive medications, fetal acidosis, 
uteroplacental blood flow and impaired fetal oxygenation. The time limit of the search 
was from January 2001 to January 2017. 
Cesarean Deliveries and Spinal Anesthesia 
Cesarean sections (C-sections) are the most commonly performed operation in the 
United States (US) (Gunda, Malinowski, Tegginmath, Suryanarayana & Chandra, 2010).  
As reported by the Center for Disease Control and Prevention, birth by C-section 
accounts for over 32% of all deliveries and is performed over 1.2 million times annually 
in the US. The indications for C-sections include fetal positioning, declining fetal status, 
the failure to progress, malpresentation, cephalopelvic disproportion (CPD), prematurity, 
prior cesarean delivery and prior uterine surgery (Nagelhout et al.). 
Regional anesthesia in C-sections offers a significant benefit over general 
anesthesia. Spinal anesthesia provides a rapid onset of dense symmetrical anesthesia and 
has an endpoint of cerebrospinal fluid as confirmation of placement (Suresh, Segal, 
Preston, Fernando & Mason, 2012). Spinal anesthetics are relatively inexpensive and 
have become the preferred anesthetic because of the superior quality of surgical 
anesthesia, shorter onset time, less patient discomfort, and fewer complications than with 
epidural and general anesthesia (Suresh et al.). 
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Although there are several benefits to using spinal anesthesia, it is not without 
complications.  Hypotension is the most common side effect of spinal anesthesia because 
of the profound sympathectomy produced (Suresh et al.). 
Maternal Hypotension: Definition and Contributing Factors 
Maternal hypotension is defined as a 20% decrease from baseline or a systolic 
pressure less than 100 mmHg (Nagelhout et al., 2013). Several factors in pregnancy 
physiology along with local anesthetic pharmacodynamics can contribute to the high 
incidence and severity of hypotension under spinal anesthesia: the level of the block; the 
concentration or density of the sensory block required for the procedure; local anesthetic 
sympathetic block; the role of aortocaval compression; and a decrease in arteriolar tone 
(Mercier et al., 2013).  
The level of block contributes to maternal hypotension due to the vasodilating 
effects of the local anesthetic combined with the anatomical position at which the block is 
being administered and concentration of arteries and veins in the area (Miller & Pardo, 
2011). The greater the concentration of the block or denisty of the block, along with the 
greater presence of arteries and/or veins in the anatomical area, the more likely to result 
in an  increased sympathectomy and therefore hypotension (Miller & Pardo). Local 
anesthetics also cause a sympathetic block and therefore result in parasympathetic 
override which can result in hypotension due to a decrease in venous return to the heart, a 
decrease in cardiac output and a decrease in systemic vascular resistance (Miller & 
Pardo). Local anesthetics vasodilator effect largely impacts arteries, resulting in a 
decrease in arteriolar tone which can contribute to the incidence and severity of 
hypotension in spinal anesthesia (Miller & Pardo). This decrease in arteriolar tone is the 
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main mechanism and supports why vasopressors are the most important option in the 
management of hypotension (Mercier et al., 2013).   
 Aortocaval compression, defined as compression of the vena cava when lying in 
the supine position due to the gravid uterus, causes a decrease in venous return to the 
heart and therefore hypotension. This can significantly contribute to the hypotension 
already caused by local anesthetics vasodilation (Nagelhout, et al., 2013). Aortocaval 
compression is a major contributor to hypotension in pregnant women based on female 
physiology and is a syndrome of supine hypotension in term or near-term pregnant 
women (Nagelhout et al.). The compression of the vena cava can worsen when the 
abdomen is tense or when the uterus is larger than normal.  This decrease in venous 
return results in a significant reduction in stroke volume and decreases cardiac output.  
Nagelhout et al. elaborated that the normal physiological response to aortocaval 
compression is tachycardia and vasoconstriction of the lower extremities. Despite this 
compensation, uterine blood flow and therefore fetal oxygenation is reduced. 
Compression of the aorta and vena cava is usually relieved by shifting the uterus to the 
left. Prevention of aortocaval compression is universally recommended to prevent 
hypotension and avoid the risk of abrupt fall in venous return and thus decreased cardiac 
output and blood pressure (Mercier et al., 2013).  During patient placement for cesarean 
delivery, a wedge placed under the right hip or operating room table tilted left is used to 
relieve aorta or vena cava compression (Mercier et al.).   
Maternal Hypotension and Fetal Acidosis with Spinal Anesthesia  
Prolonged maternal hypotension may result in uteroplacental hypo-perfusion and 
therefore fetal acidosis (Gunda et al., 2010).  Fetal hypoxia can occur when maternal 
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perfusion of the placenta is reduced or delivery of oxygenated blood from the placenta to 
the fetus is impeded (Omo-Aghoja, 2014).  When fetal hypoxia is present, metabolism 
proceeds via an anaerobic pathway and therefore lactic acid is produced, which can 
accumulate and result in metabolic acidosis (Omo-Aghoja). Umbilical cord blood 
sampling is performed to examine blood from the fetal umbilical cord to detect fetal 
abnormalities (Huch, Huch & Rooth, 1994). Blood from the umbilical vein reflects the 
placental function whereas blood from the umbilical arteries reflects blood coming from 
the fetus (Huch et al.).  Hypo-perfusion on the maternal side can cause a decrease in 
partial pressure of oxygen (PO2) in the umbilical vein; a low umbilical artery oxygen 
level (PaO2) indicates a risk of fetal tissue hypoxia (Huch et al.). Umbilical cord blood 
sampling is indicated when umbilical cord blood gas levels and percent of hydrogen (pH) 
are needed to aid in the diagnosis of certain conditions such as fetal acidosis (Huch et al.). 
Fetal acidosis is defined as a pH less than 7.16, with adverse neonatal outcomes occurring 
with a pH less than 7.0 (Omo-Aghoja, 2014).   
The Apgar score provides an accepted and convenient method for reporting the 
status of the newborn infant immediately after birth (American Academy of Pediatrics, 
2015). The Apgar score is comprised of five components including color, heart rate, 
reflexes, muscle tone, and respirations. Each element is given a score of 0, 1, or 2. The 
score is reported at one minute and five minutes after birth for all infants and at five -
minute intervals after that for infants with a score less than 7, up to 20 minutes (American 
Academy of Pediatrics). The Apgar score quantifies clinical signs of neonatal depression 
with free signs of cyanosis, pallor, bradycardia, depressed reflex response to stimulation, 
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hypotonia and apnea or gasping respirations. All of these symptoms may be present when 
a neonate experiences fetal acidosis (American Academy of Pediatrics).   
Treatment of Maternal Hypotension 
Vasopressors are the most important option in the management of hypotension 
(Mercier et al., 2013). Ephedrine and phenylephrine are two vasoactive drugs that have 
been reported to not change the blood flow to the fetus and therefore are drugs of choice 
in obstetric patients (Nagelhout et al., 2013). Until recently, ephedrine was the more 
favored agent in treating maternal hypotension but several studies have shown that 
ephedrine risk may outweigh its benefits. As a result, there has been an increase in 
practitioners’ use of phenylephrine to treat maternal hypotension (Mercier et al., 2013). 
Each drug will be briefly reviewed next. 
            Ephedrine: Pharmacokinetics and Indications for Treatment of Maternal 
Hypotension. Ephedrine is a mixed acting adrenergic receptor agonist that has both alpha 
and beta agonist properties (Nagelhout et al., 2013). The adopted use of ephedrine was 
initially supported by a  study conducted by Ralston and Shnider (1974) that examined 
sheep to determine uterine blood flow with different vasopressors. Results showed that 
ephedrine preserved uterine blood flow, while drugs with increasing alpha agonist 
properties produced potent vasoconstriction of the uterine vascular bed. A landmark 
study performed by Kang in 1982 showed that a continuous infusion of ephedrine was 
extremely effective at preventing maternal hypotension during elective caesarean 
delivery versus a control group that received ephedrine only when hypotension occurred.  
Ralston and Shnider’s study results were reinforced when McGrath et al. (1994) 
performed a similar study with a randomized design. These authors confirmed that unlike 
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phenylephrine, ephedrine improved uterine blood flow without increasing uterine 
vascular resistance when given after epidural anesthesia-induced hypotension. Later 
studies, which will be reported in the next section, compared the use of ephedrine and 
phenylephrine. 
            Phenylephrine: Pharmacokinetics and Indications for Treatment of 
Maternal Hypotension. Phenylephrine is a pure alpha-adrenergic agonist that increases 
the blood pressure through peripheral vasoconstriction (Nagelhout et al.). In the 1990s, 
phenylephrine began to be used more cautiously in clinical practice as a rescue 
vasopressor to control maternal hypotension, tachycardia and other symptoms when 
ephedrine had failed (Taylor & Tunstall, 1991). Subsequently, direct comparison of 
ephedrine and phenylephrine began to challenge the standard use of ephedrine by 
reporting that the pure alpha agonist produced a better umbilical artery pH (Morgan, 
1994). In 2002, Lee et al. performed a meta-analysis of six trials (n=200) comparing 
ephedrine and phenylephrine used to treat maternal hypotension with spinal anesthesia 
for cesarean delivery. Results suggested that phenylephrine resulted in better umbilical 
arterial pH than ephedrine but no difference in the incidence of true fetal acidosis or 
Apgar score below 7 at 1 minute (RR of 0.77; 95% CI, 0.17-3.51) and five minutes (RR 
of 1.00; 95% CI, 0.21-4.83) after birth. Pooling the results showed that women given 
phenylephrine had neonates with higher umbilical arterial pH values than those given 
ephedrine (WMD = 0.03; 95% CI, 0.02-0.04, mean ephedrine umbilical arterial pH 
values ranging from 7.27-7.29). Also, women given phenylephrine had neonates with 
greater venous pH values than those given ephedrine (WMD = 0.02; 95% CI, 0.01-0.03, 
mean ephedrine venous pH values ranging from 7.29-7.35). The risk of true fetal 
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acidosis, which was defined as a pH value of <7.20, was similar between the 
phenylephrine and ephedrine groups (RR of 0.78; 95% CI, 0.16-3.92) (Lee et al.). 
             Phenylephrine has been demonstrated to be detrimental to the well-being of the 
fetus, based on numerous animal models (Mercier et al., 2013).  When ephedrine began 
to be reported to cross the placental barrier easily and cause a decrease in umbilical 
arterial pH or ephedrine failed to treat the maternal hypotension, phenylephrine began to 
be used cautiously (Mercier et al.). While phenylephrine effectively prevents hypotension 
and provides a proper neonatal pH, it can cause bradycardia (Mercier et al.).  The 
mechanism is thought to be due to a baroreceptor-mediated response in cardiac afterload 
due to increased systemic vascular resistance. The response may also be due to cardiac 
sympathetic denervation associated with spinal blocks which could be masked when 
ephedrine is used because of its beta-adrenergic chronotropic effect (Mercier et al.). This 
bradycardia may result in a decrease in cardiac output which can further harm the fetus 
(Mercier et al.).  Further analysis of ephedrine and phenylephrine specific to impact on 
maternal hypotension and fetal outcomes is indicated.  
Next, the frameworks used to guide this review will be presented. 
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Theoretical Frameworks 
 
 Systematic reviews and meta-analyses are a vital component of evidence-based 
healthcare and as such they support the development of clinical practice guidelines and 
inform clinical decision-making (Moher et al., 2015). The Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) is used to accurately report high-
quality systematic reviews as well as meta-analyses. PRISMA was created in 2009 after 
the previously used Quality of Reporting of Meta-Analysis (QUOROM) statement (1999) 
was revised (Atlman et al., 2009). The new PRISMA statement allows for standardization 
and improvement of the quality of the systematic reviews being produced (Atlman et al.). 
Although the PRISMA update in 2009 was thought to correct many missing pieces and to 
promote consistency to systematic review research, there remained the issue of how to 
include studies with greater than two interventions. To address this issue, experts in 
research added five more items to the checklist, in the methodology section (Moher et al., 
2015).  Since this author will only be examining two primary variables, ephedrine and 
phenylephrine, the 2009 PRISMA checklist, as well as the 2009 flow diagram, will be 
used. The flowchart was modified to include the number of articles identified, those 
included as well as those excluded (Moher et al., 2009). The 27-item checklist was 
created with items thought to be necessary for transparency of data (Moher et al.). The 
items on the checklist give researchers a step-by-step guide while allowing them to 
present their research in an accurate and succinct manner (Moher et al.).  
             The PRISMA statement consists of a 27 item checklist (Table 1) which lays out 
the requirements for evidence-based studies (Moher et al., 2009). Table 1 can be viewed 
on the next page. Items on the checklist include seven major sections including title, 
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abstract, introduction, methods, results, discussion, and funding. Within each heading are 
subheadings as well as descriptions defining the expectations for each of the sections. 
The PRISMA checklist will be used to ensure that all items required to complete a 
systematic review are presented in the completion of the research. 
  Table 1 
 
 PRISMA Checklist 
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Along with the checklist is the PRISMA four-phase flow diagram (Figure 1) that 
helps to dictate the literature search procedure (Moher et al.,). The flow chart illustrated 
below elucidates the screening and evaluation for eligibility within the research.  
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
Figure 1. PRISMA Flow Diagram. This figure illustrates the PRISMA statements flow 
diagram used for the search strategy performed when conducting a systematic review and 
to evaluate the eligibility of studies. 
 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
flowchart supports the attainment of appropriate research. This flowchart also provides a 
step-by-step set of instructions for articles included for analysis. The flow diagram 
outlines the records excluded from the study and ask for reasons why to be reported 
(Moher et al., 2009). It begins with the identification of articles through database 
searching, the screening of such items for appropriateness and eligibility, and ends with 
the final articles to be included within the research; the process can be reviewed in Figure 
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1 (Moher et al., 2009). PRISMA may also be useful for critical appraisal of published 
systematic reviews but is not a quality assessment instrument (Moher et al.) 
 The Critical Appraisal for Summaries of Evidence (CASE) worksheet (Table 2) is 
used to assess the quality of evidence (Foster & Shurtz, 2013) and will be used to 
critically appraise the studies.  
 Table 2 
  
 CASE Worksheet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The CASE worksheet is comprised of 10 questions examining specificity, 
authorship, reviewers, methods, grading, clarity, citations, currency, bias, and relevancy 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		
Not	completely-	
No-	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Yes-		
Not	completely-	
No-	
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
Yes-		
Not	completely-		
No-		
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-		
Not	completely-		
No-	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-		
Not	completely-		
No-	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-		
Not	completely-	
No-		
7. Are	the	recommendations	appropriately	
cited?	
Yes-	
Not	completely-		
No-		
8. Are	the	recommendations	current?	 Yes-		
Not	completely-	
No-	
9. Is	the	summary	unbiased?	 Yes-		
Not	completely-	
No-	
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-		
Not	completely-	
No-	
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of each study (Foster & Shurtz, 2013).  The researcher must answer these questions as 
either “yes”, “no”, or “not completely”. Traditionally, the CASE worksheet is utilized to 
assess the quality of point-of-care tools and treatment modalities that directly effect 
patient outcomes. The quality assessment data within the studies will be determined 
through the application of the CASE Worksheet. Each study will be appraised through 
answering the ten CASE worksheet questions and then all the studies will be compared 
based on the results and listed from highest to lowest quality, one being the highest 
quality and five being the lowest quality based on the CASE worksheet results. 
            Cross study analysis was conducted using a process called descriptive data 
synthesis, which can be accomplished by both a narrative and a tabulation approach 
(Evans, 2002). This process will be further described in the methods section. 
 Next, the methods used to conduct this systematic review will be discussed.  
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Method 
 
Purpose of Study/Clinical Question 
           The purpose of this systematic review was to compare the safety and efficacy of 
the use of ephedrine versus phenylephrine in managing maternal hypotension during 
spinal anesthesia for cesarean delivery. The effects of ephedrine and phenylephrine on 
uteroplacental blood flow and fetal outcome was specifically examined. 
The question posed was: Is either ephedrine or phenylephrine more effective and 
safer when used to treat hypotension during spinal anesthesia for cesarean delivery?  
Outcomes Examined 
           The specific outcomes assessed included maternal blood pressure, maternal heart 
rate, fetal acidosis as measured by neonatal umbilical cord blood arterial and/or venous 
pH and Apgar score. 
Inclusion and exclusion criteria 
Inclusion criteria encompassed: studies specific to cesarean delivery with spinal 
anesthesia that examined: maternal hypotension; ephedrine and phenylephrine; fetal 
acidosis with or without Apgar scores. Only randomized control trials or systematic 
reviews published from January 2001 to January 2017 were included. Exclusion included 
any studies before January 2001 and those not meeting all of the inclusion criteria. 
Search Strategy 
Applying both the PRISMA flowchart as well as the PRISMA checklist, research 
articles were obtained from the database PubMed. The search was conducted using the 
terms cesarean delivery, cesarean delivery complications, spinal anesthesia, hypotension, 
maternal hypotension, Ephedrine, Phenylephrine, vasoactive medications, fetal acidosis, 
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uteroplacental blood flow and impaired fetal oxygenation. The results of the search were 
applied to the PRISMA flow diagram (Figure 1) to support selection for inclusion in the 
systematic review.   
After removing any duplicates located, the investigator then assessed the 
remainder of the studies for inclusion criteria. Eligibility assessment was performed 
independently in an unblinded and unbiased standardized manner by the student 
researcher. Initial steps involved first reviewing both title and abstract for eligibility. The 
remaining studies were then further screened for eligibility through examination of the 
entire study and the reasons for exclusion of those that did not qualify was noted. The 
number of articles being used for data synthesis were identified (PRISMA, 2009). 
Data Collection for Each Study 
 Table 3 served as a data collection table to organize pertinent data from each 
study. This table was used to organize and summarize information gathered from the 
research articles included in the study and ensured that all required criteria as stated by 
PRISMA were captured.  
  
 
Method/Level 
of evidence & 
Major 
Variables 
Studied 
Sample/setting Intervention Data Analysis Results limitations 
      
      
Table 3 
Data Collection Tool 
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Critical Appraisal Tool  
 The purpose of a critical appraisal is to determine how credible the study is in 
practice (Fineout-Overholt, Melnky, Stillwell & Williamson, 2010). The quality 
assessment data within the studies was determined through the application of the CASE 
Worksheet (Table 2) illustrated earlier in the framework section. All 10 questions 
examining specificity, authorship, reviewers, methods, grading, clarity, citations, 
currency, bias, and relevancy of each study were answered. The hierarchy of evidence for 
assessing healthcare research will also be used to determine the level of evidence of each 
study (Melnyk & Fineout-Overholt, 2011). 
Descriptive data synthesis  
Descriptive data synthesis can be attained by both means of a narrative and also a 
tabulation approach to describe the literature (Evans, 2002). Evans (2002) stated that 
using both narrative and tabulation data synthesis allows a more comprehensive view of 
the literature by decreasing limitations than if just one method was used. A narrative was 
completed to summarize the studies individually as well as across each study in order to 
identify themes and patterns. The outcome of safety and efficacy of the use of ephedrine 
versus phenylephrine was examined and further tabulated into more detail in Table 4, 
illustrated on the next page and then examined for comparisons across the studies. 
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Through the descriptive data synthesis and comparison across the studies, the 
following questions were addressed:  
• Which medication causes less umbilical cord arterial and/or venous blood 
acidosis: phenylephrine or ephedrine? 
• Which medication causes the least decrease in infant Apgar scores: phenylephrine 
or ephedrine? 
• Was oxygen administered to the mother during c-section and could this be 
correlated with fetal acidosis? 
• Was the mother administered IV pre-hydration prior to the spinal that could effect 
the incidence of hypotension seen? 
• What were the characteristics of the patient studied? 
• Was there a correlation between hypotension after spinal anesthesia and the spinal 
anesthesia medication used? 
• Were there any incidental findings that can be contributed to fetal acidosis? 
      Next, study results will be presented. 
 
 
	
Study	
Oxygen	
supplementation	
Used	
Intravenous	
Fluid	
Prehydration	
ASA	
Classification/patient	
characteristics	
Hypotension	
incidence	after	
spinal	anesthesia	
Spinal		
Solution	and	
Technique	
Umbilical	
artery	pH	
Apgar	
scores	
N/V	
during	
case	
Other	
important	
findings	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	
Table	4	
	
Descriptive	Data	Synthesis	Tool	
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Results  
 The PRISMA flowchart (Figure 2), illustrated below, along with the inclusion and 
exclusion criteria aforementioned, were used to further eliminate and select articles for 
the systematic review. After the database search, a total of 44 non-duplicate citations 
were screened. The abstracts of these articles were reviewed for evidence of exclusion 
criteria that would deem them not appropriate for the systematic review. This process 
eliminated a total of 22 articles. The remaining 22 articles were reviewed in their entirety 
for relevance and selected for the systematic review based on both exclusion and 
inclusion criteria. The final elimination process omitted 16 articles, leaving a total of six 
articles for inclusion within the final systematic review. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Search Strategy Using PRISMA Flow Diagram. This figure illustrates the 
search strategy performed and applies the results found to the PRISMA flow diagram. 
 
 Of the six articles that remained, five were randomized control trials and one was 
a retrospective observational and chart review study. The following section summarizes 
	
PubMed	January	2001-	
January	2017	
44	Citation(s)	
44	Non-Duplicate	
Citations	Screened	
Inclusion/Exclusion	criteria	
applied	
22	Excluded	After	title/abstract	
screened	
22	Articles	Retrieved	
Inclusion/Exclusion	criteria	
applied	 16	Excluded	After	Full	text	screened	
6	Articles	Included	
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each individual study as derived from the data collection tool (Appendix A) after the 
summary of each study, a critical analysis of the study is provided (Appendix B). The 
retrospective chart review will be reviewed first, followed by the RCTs which will be 
presented chronologically. 
 The retrospective observational study and chart review conducted by Cooper et al. 
(2010) (Appendix A-1) included 385 women with high risk pregnancies that had a 
cesarean section under spinal anesthesia for singleton delivery where fetal umbilical 
artery and venous pH were recorded. Charts were reviewed within a four-year period 
from 2000-2003. Once women for the study were identified, the authors then reviewed 
the notes, recording maternal and fetal demographic and operative data. Blood gas 
values, taken from a double clamped segment of umbilical cord at delivery and five 
minute Apgar scores assessed by a midwife upon admission to the neonatal unit were all 
recorded. During the study, ephedrine was routinely given as 6mg boluses and 
phenylephrine as 100 mcg boluses, at the discretion of the anesthetist. Phenylephrine was 
started at 33 mcg/min immediately following spinal injection and then titrated, aiming to 
keep systolic blood pressure (SBP) at baseline. The infusion rate was doubled or halved 
as required. The maximum infusion rate was 67 mcg/min. If there was hypotension 
despite the prophylactic infusion, 100 mcg boluses of phenylephrine were given. There 
were no guidelines for ephedrine infusion. 
            One hundred and twelve participants per group would give the study an 80% 
chance of detecting a 0.03 difference in umbilical artery pH, at P=0.05, based on a 
standard deviation of 0.08 for umbilical artery pH for non-elective C-section under spinal 
anesthesia. Secondary outcomes were the incidence of fetal acidosis (pH <7.20), low 5 
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minute Apgar score (<7) and admission to the neonatal unit. Mann-Whitney and Kruskal-
Wallis tests were used for direct comparison of the groups and subgroups. Forward 
stepwise multiple regression analysis was used to find which independent variables were 
associated with umbilical artery pH. Results revealed that there was no difference in 
umbilical artery pH between the three groups on direct comparison (P=0.21). Following 
forward stepwise multiple regression analysis, the only variable that was associated with 
altered pH was non-reassuring fetal heart rate trace (P=0.71). 
 Critical analysis of the Cooper et al. (2010) study using the CASE worksheet 
(Appendix B-1) found that the study met six out of 10 criterions. The authors clearly 
identified the aim of the study as well as the patients that the study applied to. Although 
the individual authors were identified with their affiliations, their credentialing was not 
listed. Whether the study was edited or reviewed was also not clearly stated. The 
inclusion and exclusion criteria and protocol for the study were clearly stated. The study 
was a retrospective observational chart review study therefore level IV evidence based on 
the hierarchy of evidence (Melnyk & Fineout-Overholt, 2011). The protocol used in 
reviewing the charts was clearly stated.  Although recommendations for practice were not 
current, they were clearly stated and multiple options for treatment were provided and 
could be applied to any setting and population. It was unable to be determined if there 
was a conflict of interest. 
 Cooper et al. (2002) (Appendix A-2) conducted a randomized/double blind study 
including 147 ASA I and II women scheduled for elective C-section of a singleton 
pregnancy under spinal anesthesia with no other comorbidities. Before entering the 
operating room, vital signs were taken three times and the lowest of the three was 
 
	
22	
considered the baseline. Baseline nausea and vomiting scores were also assessed. The 
participants, anesthetists, nurses and midwives involved were all blinded to the patient 
grouping. There were three groups: The P group received phenylephrine 100mcg/ml; the 
E group received ephedrine 3mg/ml; and the C group received a combination of 
phenylephrine 50mcg/ml combined with ephedrine 1.5mg/ml. One of four spinal 
anesthetics techniques was used based on provider preference. Immediately before spinal 
anesthesia, a preload of 10ml/kg of Hartmann solution was rapidly infused. Immediately 
following spinal injection, the infusion of IV vasopressor solution was started according 
to protocol. The patient was then positioned supine with a left lateral tilt. Systolic arterial 
pressure and heart rate were measured every minute. The rate of the solution was doubled 
or halved if the systolic arterial blood pressure (BP) fell below or above 0.75 times the 
baseline. Phenylephrine was started at 33mcg/min; ephedrine was started at 1mg/min or 
half the dose rate for each for the combination solution. The maximum nausea and 
vomiting score was recorded between spinal and delivery. At delivery, one of the 
investigators obtained umbilical artery and vein blood samples from a segment of the 
umbilical cord double clamped before the babies’ first breath. No supplemental O2 was 
given to the mother prior to delivery. The APGAR scores were recorded at one and five 
minutes by a midwife. The Kruskal-Wallis test was used to compare the three groups. If a 
difference was found with the Kruskal-Wallis test, pairs of groups were then compared 
using the Mann-Whitney U test. The Wilcoxon signed-rank test and spearman rank test 
were also used to analyze data. The Wilcoxon signed-rank test was used to compare data 
within a group.  
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          All participants were comparable for age, height, weight, gestation, breech 
presentation, previous c-section, delivery and birth weight. Forty-eight participants in the 
phenylephrine group (P group), 50 in the ephedrine group (E Group) and 49 in 
combination of phenylephrine and ephedrine solution group (C group) were studied. Fetal 
acidosis was less frequent in the P group (1 of 48) and less frequent in the C group (1 of 
47) than in the E group (10 of 48), (overall P=0.0007). There was no difference in the 
incidence of fetal acidosis between the P and C groups (P=0.99). One and five min 
APGAR scores were normal in all three groups. Blood gas values were similar for the P 
and C groups; the E group had a lower umbilical artery pH than the P group (P=0.002) or 
the C group (P=0.009) and a lower umbilical vein pH than the P group (P=0.04) or the C 
group (P=0.003). There was no difference in the umbilical vein PCO2 between the 
groups but the E group had a higher umbilical artery PCO2 than the P group (P=0.002). 
There was no change in the P group from baseline N/V scores (P=0.30) but in the E and 
C group the N/V scores increased from baseline (E= P<0.0001) (C = P=0.007). The N/V 
scores were lower in the P group than in the E group (P<0.0001) or C group (P<0.0001) 
but there was no significant difference between the E and C groups (P=0.09). In the E 
group, vomiting (n=18) was associated with decreased HR and SABP and increased 
ephedrine doses. The incidence of fetal acidosis and vomiting at cesarean delivery under 
spinal anesthesia was reduced by giving phenylephrine alone or in combination with 
ephedrine versus giving ephedrine alone.  
 The CASE worksheet was then applied to the study by Cooper et al. (2002) 
(Appendix B-2). The study was found to meet seven out of ten criteria. The aim of the 
study was clearly stated as well as the patients that the summary applied to. The 
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individual authors were listed along with their credentialing and affiliations. It was not 
clearly stated that the study had been edited and reviewed. The inclusion and exclusion 
criteria were clearly stated as well as the protocol followed for the study. This study was 
a randomized double-blinded study which is level II evidence (Melnyk & Fineout-
Overholt, 2011). The study stated that randomization was performed by randomly 
allocating patients by envelope selection to one of three groups and that all participants 
and investigators were blinded to the group and that unlabeled syringes were used. A 
third party not involved in the study opened the envelope and handed the appropriate 
medication to the investigator. The recommendations were clearly stated and multiple 
options for treatment were provided. The recommendations were from 2002 and therefore 
not current. It was unable to determine if there was a conflict of interest between the 
recommendation of the summary and the sponsor for any author. The evidence and 
setting for this study applies to many populations and settings. 
Ngan Kee et al. (2008) (Appendix A-3) performed a randomized double blind 
study of 204 ASA I and II women with singleton pregnancies scheduled for non-elective 
C-section for which spinal anesthesia was decided upon for clinical reasons at any point 
in time. Standard monitoring was applied. No IV prehydration was given. Spinal 
anesthesia was induced with the patient in the right lateral position at L3-4 or L4-5 with 
2.0-2.2 ml of hyperbaric 0.5% bupivacaine (10-20 mg) and fentanyl 15 mcg. The patients 
were then immediately turned to supine with a left lateral tilt and a rapid IV co-hydration 
with up to 2 liters of lactated ringer’s solution was administered and oxygen of 6-8 L/min  
delivered by clear facemask until delivery. Participants were randomized to receive an IV 
bolus of either phenylephrine 100 mcg (group P) or ephedrine 10 mg (group E) 
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immediately after each episode of hypotension. Umbilical arterial (UA) and umbilical 
venous (UV) blood samples from double-clamped segments of umbilical cord were 
obtained. The attending pediatrician assessed APGAR scores at one and five minutes 
after delivery. Univariate intergroup comparisons were made using the unpaired student’s 
t-test or the Mann-Whitney U-test as appropriate. Nominal data were compared using the 
Chi-Square test or Fisher’s exact test.  
          The number of doses of vasopressor required was similar between groups. More 
participants had nausea or vomiting in the E group than the P group (13/102 (12.7%) vs 
4/102 (3.9%), P=0.02). There was no difference between groups in the primary outcome, 
UA pH. In the E group, two cases had a UA pH <7.0 compared with no cases in the P 
group (P=0.50). The UA PO2 was lower in the P group vs the E group (median 
difference 0.23 [95% CI of difference 0.20-0.45]; P=0.032) and UV PO2 was lower in the 
P group vs the E group (Median difference 0.39 [95% CI of difference 0.08-0.70; 
P=0.012). However, there was no difference between groups in UA or UV oxygen 
content. There was no difference between groups in the clinical outcome of the neonates. 
Both phenylephrine and ephedrine are suitable vasopressors for use in non-elective C-
sections. 
 The study by Ngan Kee et al. (2008) was then critically appraised using the CASE 
worksheet (Appendix B-3). The study met six out of 10 criterions. The aim of the study 
was clearly stated as well as the patients that the study applied to. Although the individual 
authors and their affiliations were listed in the study, their credentialing was not. It was 
not clearly stated that the study was edited or reviewed. The inclusion and exclusion 
criteria were clearly stated as well as the protocol for the study. The study is level II 
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evidence being that it is a randomized double-blinded study (Melnyk & Fineout-
Overholt, 2011). The study stated that randomization was performed using computer 
generated codes contained in opaque, sealed and sequentially numbered envelopes as 
well as medications prepared in identical syringes by someone not involved in the study. 
Recommendations were clearly stated and multiple options for treatment were provided. 
The recommendations are not current as the study was completed in 2008. It was unable 
to determine if there was a conflict of interest between the recommendation of the 
summary and the sponsor for any author. The evidence and setting for this study applies 
to many populations and settings. 
 A randomized double blind study by Prakash et al. (2010) (Appendix A-4) studied 
60 ASA I women with singleton pregnancies scheduled for elective caesarean delivery 
under spinal anesthesia. Standard monitoring was applied. Each patient also received a 
10ml/kg IV infusion of Lactated Ringers solution over 15-20 min before spinal 
anesthesia. With participants in the left lateral position, 2ml 0.5% Hyperbaric 
Bupivacaine was injected intrathecally at L3-4. Oxygen 6L/min via face mask was given 
until delivery. Participants were divided into two groups: P group (phenylephrine) and E 
group (ephedrine). Group E received 1ml bolus of ephedrine 6mg/ml; group P received a 
1 ml bolus of phenylephrine 100 mcg/ml. Additional boluses were administered if the 
systolic pressure remained at or below 80% of baseline. The incidence of nausea and 
vomiting, arterial and venous blood samples from a double clamped segment of the 
umbilical cord and Apgar scores at one, five and ten minutes were determined by the 
attending pediatrician and all were recorded. Descriptive statistics were calculated for 
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continuous variables as mean and standard deviation and for categorical variables as 
frequency of distribution and percentage.  
          The two groups were comparable in age, weight, height, baseline hemodynamic 
data and dermatomal sensory levels. Apgar scores at one, five and ten minutes were 
comparable in the two groups with no neonate having an Apgar score < 7 at any time. No 
umbilical artery pH was less than 7.20. Umbilical artery and venous pH were 
significantly lower in group E than in group P (p=0.01 and P=0.002). Results showed that 
100 mcg bolus doses of phenylephrine were as effective as 6 mg bolus doses of ephedrine 
in the treatment of hypotension following spinal anesthesia in term parturients 
undergoing c-section delivery.  Neonates of women treated with phenylephrine had 
higher umbilical cord pH though true fetal acidosis was not seen in any neonate. 
 The study by Prakash et al. (2010) was also critically appraised using the CASE 
worksheet (Appendix B-4). The aim of the study was clearly stated as well as the patients 
that the study applies to were well described. The individual authors and their affiliations 
were listed but credentialing was not. It was not clearly stated if the study was edited or 
reviewed. The inclusion and exclusion criteria were clearly stated as well as the study 
protocol that was followed. This study was a randomized double-blinded study making it 
level II evidence (Melnyk & Fineout-Overholt, 2011). The randomization was performed 
by computer generated number allocation and identical syringes prepared by someone not 
involved with data collection were utilized. Recommendations for practice were clearly 
stated and multiple options for treatment were provided. The recommendations are from 
2009 and therefore not current. It was unable to determine if there is a conflict of interest 
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between the recommendation of the summary and the sponsor for any author. The 
evidence and setting for this study applies to many populations and settings. 
 A randomized double blind study completed by Mercier et al. (2013) (Appendix 
A-5) included 42 ASA I and II women with singleton pregnancies scheduled for 
caesarean section delivery under spinal anesthesia. Standard monitors and oxygen via 
nasal cannula were applied. Baseline vitals signs were obtained.  Intravenous preload of 
15ml/kg Lactated Ringer’s solution was given prior to spinal anesthesia of 11mg of 
hyperbaric 0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg morphine at L2/3 or L3/4. 
A prophylactic vasopressor IV infusion was started at the end of spinal injection. 
Participants received either 2mg/min ephedrine plus 10 mcg/min phenylephrine (E+P 
group) or 2mg/min ephedrine alone (E group). Infusions were halved, stopped or doubled 
based on study protocol. Groups were compared for single parametric, ordinal and 
nominal variables using unpaired student t test, the Mann-Whitney U test, and Fisher 
exact test, respectively. Hemodynamic values over time were compared using analysis of 
variance for repeated measures, followed by Dunnett tests.  
           Participants were all comparable for demographic characteristics, gestational age, 
neonatal weight, upper sensory level of anesthesia, time from spinal anesthesia to 
incision, time from spinal anesthesia to delivery and from uterine incision to delivery, 
baseline SBP and maternal HR. Umbilical venous and arterial pH values were 
significantly higher in the E+P group. The incidence of arterial pH <7.20 was 31% higher 
in the E+P group and 63% in the E group (P=0.09). However, Apgar scores at one and 
five minutes were similar in both groups and were never less than 7. Low venous and 
arterial pH values were associated only with the E group assignment and spinal 
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anesthesia to delivery times longer than 33 min. Compared with ephedrine alone, 
ephedrine plus phenylephrine infusions decreased the incidence of hypotension by 
approximately 50%, abolished maternal tachycardia and improved venous and arterial 
pH. 
 The CASE worksheet was applied to the study by Mercier et al. (2013) (Appendix 
B-5). The study met seven out of 10 criterion of the CASE worksheet. The aim of the 
study was clearly stated and the patients that the aim applied to were well described. The 
individual authors were listed along with their credentialing and affiliations. The 
inclusion and exclusion criteria were clearly stated and a protocol for the study was stated 
and followed. This study was a randomized double-blinded study therefore making it 
level II evidence (Melnyk & Fineout-Overholt, 2011). The study stated that 
randomization was performed by using numbered, sealed, opaque envelopes ensuring 
both the patient and investigators were blinded to group assignment and study solutions 
were prepared by those not involved in the patient’s care and according to the group 
indicated by the envelope. There was an investigator present during the study period to 
confirm comparability and routine procedures. The recommendations for practice were 
clearly stated and multiple options for treatment were provided even though the evidence 
was not considered current. It was unable to determine if there was a conflict of interest 
between the recommendation of the summary and the sponsor for any author. The 
evidence and setting for this study applies to many populations and settings. 
 Moslemi & Rasooli (2015) (Appendix A-6) performed a randomized double blind 
study which included 83 healthy pregnant women with gestational age of 36 weeks or 
greater for elective cesarean section under spinal anesthesia. Participants were assigned to 
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three different groups: phenylephrine (group Ph), ephedrine (group E) and placebo (group 
P). Standard monitoring was applied. Prior to spinal anesthesia, all participants received a 
500 ml crystalloid bolus. Infusion of study drugs were: group Ph received 450 mcg of 
phenylephrine in 250 ml; group E received 45 mg of ephedrine in 250 ml; and group P 
received an infusion of only 250 ml normal saline. The participants then received spinal 
anesthesia in the sitting position at L4/5 or L3/4 with 2.5 ml of Bupivacaine 0.5% 
(12.5mg) and 2.5 mcg of Sufentanil. After delivery and clamping of the umbilical cord, 
1ml of blood was drawn from the umbilical artery for neonatal blood gas analysis. One 
minute and five minute APGAR scores were recorded as well as the umbilical artery 
blood gas analysis. Any decrease in BP of about 20% from baseline was treated with 50-
100 mcg phenylephrine in pH group or 5-10 mg ephedrine in E and P groups. Data were 
analyzed using a one-way ANOVA for quantitative variables and Fishers exact 
probability tests and chi-square for qualitative variables and associations. Multiple 
comparisons were tested by post-hoc with Turkey technique. Normal distributions of data 
were evaluated by Kolmogorov-Smirnov normality test.  
          There was no significant difference in demographic data. Indications for c-section 
included repeated c-section (n=53), other indications (n=25) and patient preference (n=4). 
Additional doses required for the treatment of hypotension was higher in groups E 
(65.2%, n=15) and P (80%, n=20) than in group Ph (28.57%, n=10). There was a 
significant difference in the 5 min APGAR scores which was better with group Ph and E 
rather than group P (P=0.002). Umbilical artery (UA) blood gas analysis showed a 
significant difference in pH and PCO2 between Ph and P groups. Two neonates in the Ph 
group, seven in the E group and five in the P group had acidosis. Acidosis was 
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significantly lower in phenylephrine group (P=0.043). Overall results showed that for 
women who underwent spinal anesthesia for elective c-section, SBPs and neonatal UA 
pH were best maintained with a prophylactic infusion of phenylephrine compared with 
those who did not receive it and were even better than those who received prophylactic 
ephedrine. 
 Finally, the study by Moslemi & Rasooli (2015) was critically appraised using the 
CASE worksheet (appendix B-6). The study met eight out of 10 criterion. The aim of the 
study was clearly stated and the patients that the study applied to were well described. 
The individual authors were listed along with their credentialing and affiliation. It was 
not clearly stated if the study was edited or reviewed. The inclusion and exclusion criteria 
were clearly stated as well as the protocol used. This study was a randomized clinical trial 
making it level II evidence (Melnyk & Fineout-Overholt, 2011). The study stated that 
randomization was performed using a table of random numbers and computer generated 
randomization list. Recommendations for practice were clearly stated and multiple 
options for treatment were provided; the recommendations were from 2015 making them 
current. It was unable to appropriately assess if there was a conflict of interest between 
the recommendation of the summary and the sponsor for any author. The evidence and 
setting for this study applies to many populations and settings. 
 
Cross Study Analysis 
 
All but one of the studies included in this systematic review were randomized 
control trials; the Cooper et al. (2010) study was a retrospective chart review study. 
Descriptive data synthesis of the included studies are illustrated in Appendix C. Key 
variables were identified and analyzed across the six studies.  All six studies had different 
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intervention groups; some included a combination of medications and some contained a 
placebo group. The sample size for all six studies were comparable and appropriate to 
determine statistical significance at the level of P<0.05 in all the studies. 
The use of oxygen supplementation was determined to be beneficial in the time 
preceding fetal umbilical clamping and is associated with higher maternal and fetal 
oxygen levels (Chatmongkolchart & Prathep, 2013). Cooper et al. (2002) reported that 
they did not use supplemental oxygen at any time before delivery of the neonate, whereas 
Ngan Kee et al. (2008), Prakash et al. (2010) and Mercier et al. (2013) all administered 
supplemental oxygen to participants. Mercier et al. (2013) reported an unknown amount 
of oxygen administered via nasal cannula whereas both Ngan Kee et al. (2008) and 
Prakash et al. (2010) both reported administration of oxygen via facemask of 6-8 liters. 
Moslemi and Rasooli, (2015) and Copper et al. (2010) did not report on whether their 
participants were given any oxygen supplementation. Since this use of oxygen 
supplementation was demonstrated to be beneficial in other studies (Ngan Kee et 
al.,2008; Mercier et al. (2013), Prakash et al.,2010), results of the Cooper et al. (2002) 
study could have provided results of more fetal acidosis when compared to a similar 
study with the use of supplemental oxygenation. The Cooper et al. (2002) study did find 
that a lower pH was more frequent with ephedrine (10 out of 48) than with phenylephrine 
(1 out of 48) or combination of both groups (1 out of 47) (overall P=0.0007) but puts into 
question that if supplemental oxygen was given, would there be as many neonates with a 
low pH in the ephedrine group? 
The use of fluid prehydration before spinal administration has been demonstrated 
to decrease the incidence of hypotension caused from spinal anesthesia (Riley, Cohen, 
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Rubenstein & Flanagan, 1995).  Cooper et al. (2002), Prakash et al. (2010), Mercier et al. 
(2013) and Moslemi and Rasooli (2015) all administered some sort of prehydration to 
their participants. Cooper et al. (2002), Prakash et al. (2010) and Mercier et al. (2013) all 
administered a weight-based amount of fluid, while Moslemi and Rasooli (2015) only 
administered a set 500ml boluses of prehydration to participants. Cooper et al (2010) did 
not report on whether any prehydration was administered. Ngan Kee et al. (2008) did not 
administer any hydration before spinal anesthesia but instead administered up to two 
liters of Lactated Ringers solution as needed after spinal anesthesia was given. Although 
the use of prehydration has been demonstrated to be helpful (Riley et al., 1995) it did not 
seem to effect the variables in question. For example, in the Ngan Kee et al. (2008) no 
prehydration was used and only 2 out of 102 neonates in the ephedrine group experienced 
acidosis versus none in the phenylephrine group. 
 In 1941 the American Society of Anesthesiologists (ASA) published a booklet for 
it’s members containing the first version of a ‘physical status’ classification for patients 
about to undergo surgery (Fitz-Henry, 2011). The function of ASA classifying is to 
quantify the amount of physiological reserve that a patient possesses at the time of the 
assessment for a surgical procedure (Fitz-Henry, 2011). This may change before the 
patient actually undergoes the procedure, either by optimization and improvement of their 
physical state or because they deteriorate and have less reserve (Fitz-Henry). All of the 
studies but one included patients that were healthy individuals of ASA classification I or 
II with similar characteristics (none to mild systemic disturbances). Cooper et al. (2010) 
examined high risk singleton pregnant subjects with a number of different comorbidities 
such as prematurity, diabetes, labor problems, pregnancy induced hypertension and 
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hypotension. High risk parturients have the potential for fetal complications such as fetal 
acidosis and therefore cannot be compared to non-high risk parturients or healthy ASA 
class I or II patients.  For this reason, the Cooper et al. (2010) study results are not 
comparable to the other five studies included in this systematic review. 
The spinal solution used may effect the incidence of hypotension due to where the 
site of action of the anesthetic tends to be (Miller & Pardo). Hyperbaric solutions are 
heavier and tend to be lower within the intrathecal space and therefore may cause less 
sympathectomy (Miller & Pardo). Since spinal anesthesia height is based on the 
concentration and solution and not the volume of anesthesia, larger volumes give higher 
blockade and therefore more sympathectomy leading to increased incidences of 
hypotension (Miller & Pardo). Moslemi and Rasooli (2015) used 2.5 ml of Bupivacaine 
0.5% (12.5mg) with 2.5 mcg of Sufentanil. Mercier et al. (2013) administered 11mg of 
hyperbaric 0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg morphine. Prakash et al. 
(2010) administered 2ml 0.5% Hyperbaric Bupivacaine. Ngan Kee et al. (2008) 
administered 2.0-2.2 ml of hyperbaric 0.5% bupivacaine (10-20 mg) and fentanyl 15 
mcg. Cooper et al. (2010) reported no detail of solutions used but did report they were not 
consistent. Cooper et al (2002) reportedly used four different techniques which were 
chosen based on preference by whomever was administering the spinal anesthetic.             
As described previously, local anesthetics can cause a sympathetic block, resulting in 
parasympathetic override. This can produce hypotension due to a decrease in venous 
return to the heart, a decrease in cardiac output and a decrease in systemic vascular 
resistance (Miller & Pardo). The height of spinal anesthesia necessary for cesarean 
section delivery has the increased incidence of hypotension due to this sympathectomy. 
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Copper et al. (2010) reported the incidence of hypotension to be a systolic blood pressure 
less than 90 mmHg and was found to be 6.1% in the no vasopressor group 17% in the 
Ephedrine and 20% in the Phenylephrine group (P=0.005). Cooper et al. (2002) reported 
that the lowest SABP recorded was higher in the P group (80% [73-88] of baseline) than 
in the E group (73% [61-87] of baseline) (P=0.02) but the C group (77% [69-86] of 
baseline) was not significantly different from the P (P=0.14) and E (P=0.25) groups. The 
proportion of SABP readings below 80% of baseline was lower in the P group (0% [0-8]) 
(P+0.007) and in the C group (4% [0-10]) (P+0.04) than in the E group (8% [0-20]), but 
there was no difference between the P and C groups (P=0.55). Ngan Kee et al. (2008) 
reported an overall incidence of hypotension to be 74/102 (73%) of participants in the P 
group and 74/102 (73%) of the E group had one or more episodes of hypotension 
(P=0.52) and required one or more boluses of vasopressor. Prakash et al. (2010) reported 
that the mean change in systolic pressure was comparable in the two groups with the 
minimum being 100 in the E group and 93 in the P group (P=0.114) except at 8 minutes 
where E group was lower (P=0.004). Mercier et al. (2013) reported the incidence of 
hypotension was halved in the E+P (37%) group when compared with the E (75%) group 
(P=0.02). SBP values after onset of spinal anesthesia were not significantly different 
between the two groups. Moslemi, F., & Rasooli, S. (2015) reported SBP after anesthesia 
every two and every five minutes were different (P>0.050) in the Ph and P groups. 
Overall, the volume of spinal anesthetic was comparable across the studies as well as the 
incidence of hypotension after the spinal administration and consequently does not 
support identifying it as a contributing factor to the outcome of fetal acidosis. 
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 The main focus of this systematic review was to determine if ephedrine or 
phenylephrine cause more or less fetal acidosis through the diversion of fetal blood flow, 
potentially causing more harm than good when given to woman experiencing 
hypotension (Nagelhout et al). . acidosis is determined through the umbilical cord blood 
pH, specifically the artery. Fetal acidosis is defined as a pH less than 7.16 (some texts 
state 7.20), with adverse neonatal outcomes occurring with a pH less than 7.0 (Omo-
Aghoja, 2014).  Cooper et al. (2010) and Cooper et al. (2002) both found there was no 
true fetal acidosis but Cooper et al. (2002) did find that a lower pH was more frequent 
with ephedrine (10 out of 48) than with phenylephrine (1 out of 48) or combination of 
both groups (1 out of 47) (overall P=0.0007). The ephedrine group had a lower umbilical 
artery pH than the phenylephrine group (P=0.002) or the combination group (P=0.009). 
Ngan Kee, et al (2008) similarly found no statistical difference between the groups they 
studied for fetal acidosis (p=0.70). However, in the ephedrine group there were two cases 
(out of 102 cases) with umbilical artery pH less than 7.0 compared with no cases in the 
phenylephrine group (p=0.50). Prakash et al. (2010) again found that no umbilical artery 
pH was less than 7.20 but that umbilical artery and venous pH were significantly lower in 
the ephedrine group than in the phenylephrine group (p=0.01 and P=0.002) but never 
reached true acidosis.  
Mercier et al. (2013), unlike the other studies, never used phenylephrine alone as 
an intervention group; instead one group was given a combination of ephedrine and 
phenylephrine and the other was given just ephedrine alone. They found that umbilical 
venous and arterial pH values were significantly higher in the ephedrine and 
phenylephrine combination group (average = 7.24) than in the ephedrine alone group 
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(average = 7.19) (P=0.05). The incidence of arterial pH <7.20 was 31% in the ephedrine 
and phenylephrine combination group and 63% in the ephedrine alone group (P=0.09). 
Interestingly, Moslemi and Rasooli (2015) used three different intervention groups: 
phenylephrine alone; ephedrine alone; and a placebo group that received no medication. 
Umbilical artery blood gas analysis showed a significant difference in pH. Two neonates 
out of 30 in the phenylephrine group, seven out of 27 in the ephedrine group and five out 
of 26 in the placebo group had acidosis. Acidosis was significantly lower in 
phenylephrine group (P=0.043).  
Overall, out of all groups included in the different studies, the phenylephrine 
group alone provided a higher pH than any other group alone or in combination but the 
incidence of true fetal acidosis of a pH less than 7.16 (or 7.20) was extremely low and 
thus insignificant. In all six studies, Apgar scores at one and five min were similar and 
there were no statistically significant findings except for Moslemi and Rasooli (2015) 
who found that there was a significant difference in the 5 min APGAR scores which was 
better in the phenylephrine and ephedrine groups rather than the placebo group 
(P=0.002). These findings suggest that the Apgar score does not depict neonatal outcome. 
 Incidentally, nausea and vomiting were frequently studied. Nausea and vomiting 
is a side effect of hypotension but the correlation of nausea and vomiting specific to 
ephedrine or phenylephrine had not been studied. Cooper et al. (2002) and Ngan Kee et 
al. (2008) both examined nausea and vomiting in the intervention groups and both found 
that there was more nausea and vomiting in the ephedrine groups. Cooper et al. (2002) 
found that there was no change in the phenylephrine group from baseline nausea and 
vomiting (P=0.30) but in the ephedrine and combination of phenylephrine and ephedrine 
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group the nausea and vomiting increased from baseline (E= P<0.0001) (C = P=0.007). 
There was no significant different between the ephedrine and combination groups 
(P=0.09). In the E group vomiting (18 out of 48) was associated with decreased heart rate 
and systolic blood pressure and increased ephedrine doses. 
             Next, the summary and conclusions will be presented. 
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Summary and Conclusions 
 
 
              Hypotension during cesarean section delivery can have detrimental effects on 
both the mother and the neonate (Lee et al., 2002). These effects include decreased 
uteroplacental blood flow, impaired fetal oxygenation with asphyxial stress and fetal 
acidosis (Lee et al.). Some vasoactive medications have been found to be detrimental to 
the neonate and divert fetal blood flow, potentially causing more harm than good in 
pregnant women (Nagelhout et al., 2013). Studies have shown that ephedrine can cause 
fetal acidosis as a side effect and more so than phenylephrine; concerns about the adverse 
effects of phenylephrine on uterine blood flow have also been reported. Ephedrine is a 
mixed acting adrenergic receptor agonist that has both alpha and beta agonist properties. 
Ephedrine’s predominant beta effect causes an increase in arterial pressure by increasing 
cardiac output rather than by vasoconstriction. Phenylephrine is a pure alpha-adrenergic 
agonist which increases the blood pressure through peripheral vasoconstriction 
(Nagelhout et al.).  A literature review of vasoactive drugs conducted on animals varied 
in terms of the safety and efficacy of the two drugs. The results may not apply to the 
human populations and may not be appropriate because of the species differences (Lee et 
al., 2002).   
             This systematic review compared these two drugs and their efficacy on fetal and 
maternal outcomes, specifically examining fetal acidosis through umbilical artery pH 
testing. Outcomes assessed were maternal hypotension, spinal anesthetic used, 
supplemental oxygenation, intravenous prehydration, ASA classification and Apgar 
score. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) flowchart assisted in identifying appropriate research by providing a step-by-
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step approach with instructions related to those to be included as well as those to exclude 
(Moher et al., 2009). Each included study was then illustrated in a table in order to 
identify key variables being researched. The studies were then critically appraised using 
the CASE worksheet (Foster & Shurtz, 2013). Finally, a cross study analysis was done to 
examine key outcomes across the studied variables. 
            No direct conclusion can be drawn from any of the specific variables and their 
effect on fetal acidosis mainly due to the differences in study design (oxygen 
supplementation; ASA classification; IV fluid prehydration; hypotension incidence after 
spinal anesthesia; spinal solution and technique; umbilical artery pH; Apgar scores; 
nausea and vomiting during the case).  
Related to oxygen supplementation, some of the studies reported the use of 
oxygen supplementation whereas some did not report on the use while others reported no 
use. Since the use of oxygen supplementation was demonstrated to be beneficial in three 
studies, (Ngan Kee et al. [2008], Prakash et al. [2010] and Mercier et al. [2013]), studies 
where no supplemental oxygen was used could have potentially resulted in more fetal 
acidosis when compared to a similar study with the use of supplemental oxygenation. 
High risk parturients have the potential for fetal complications such as fetal 
acidosis and therefore cannot be compared to non-high risk parturients or healthy ASA 
class I or II patients. For this reason, results of the Cooper et al. (2010) study, which 
included all high risk parturients, are not comparable to the other five studies included in 
this systematic review due to the high risk nature of the patients included. 
Cooper et al. (2002), Prakash et al. (2010), Mercier et al. (2013) and Moslemi and 
Rasooli (2015) all administered some sort of prehydration to their participants. Cooper et 
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al. (2010) did not report on whether any prehydration was administered. Ngan Kee et al. 
(2008) did not administer any hydration before spinal anesthesia but instead administered 
up to two liters of Lactated Ringers solution as needed after spinal anesthesia was given. 
The late use of IV hydration or none use could have contributed to hypotension 
experienced during spinal anesthesia. 
Overall, the volume of spinal anesthetic was comparable across the studies as well 
as the incidence of hypotension after the spinal administration. Consequently, this does 
not support identifying it as a contributing factor to the outcome of fetal acidosis. 
In examining umbilical artery pH, Cooper et al. (2002), Cooper et al. (2010), 
Ngan Kee, et al. (2008), Moslemi and Rasooli (2015) , and Prakash et al. (2010) found 
that no umbilical artery pH < 7.20; however,  umbilical artery and venous pH were 
significantly lower in the ephedrine group than in the phenylephrine group but never 
reached true acidosis. In contrast, Mercier et al. (2013) used a different study design and 
found that umbilical venous and arterial pH values were significantly higher in the 
ephedrine and phenylephrine combination group (average = 7.24) than in the ephedrine 
alone group (average = 7.19) (P=0.05).  
In all six studies, Apgar scores at one and five min were similar and there were no 
statistically significant findings except for Moslemi and Rasooli (2015). These 
researchers found that there was a significant difference in the 5 min APGAR scores, 
which were better in the phenylephrine and ephedrine groups as compared to the placebo 
group (P=0.002). 
There was no difference between the two vasopressors in the incidence of true 
fetal acidosis but it is clear that the use of phenylephrine was associated with a better fetal 
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umbilical artery pH than in those women given ephedrine. Two of the studies included in 
this systematic review included nausea and vomiting as a variable and found that there 
was an increased incidence of nausea and vomiting with the administration of ephedrine. 
Incidentally, Cooper et al. (2002) and Ngan Kee et al. (2008) both examined nausea and 
vomiting in the intervention groups.  Both authors found that there was more nausea and 
vomiting in the ephedrine groups. 
 Limitations associated with this systematic review included that not all studies 
reported on the use of oxygen supplementation in their participants. The dosages, 
medications used and groups within the studies all varied across the studies, making 
comparisons difficult. The sample sizes of some of the studies were small and the 
participants included in five out of the six studies were all healthy women undergoing 
elective c-section delivery, so extrapolation to situations where fetal compromise is 
present or to emergency C-section delivery is challenging. The use of IV prehydration 
may effect the incidence of hypotension and since some studies reported they did use it 
and some did not, it is difficult to make comparisons across them.  
 In summary, this systematic review supports the cautioned use of ephedrine over 
phenylephrine in the obstetric patient experiencing maternal hypotension during spinal 
anesthesia for elective cesarean section delivery, despite limitations. The use of 
phenylephrine was associated with better fetal pH status than ephedrine. 
 Recommendations and implications for advanced nursing practice will be 
discussed in the next section. 
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Recommendations and Implications for Advanced Nursing Practice 
 
Systematic reviews provide a succinct review and critical analysis of existing 
research studies regarding the same subject matter and can therefore offer key 
information for evidence based practice. Certified Registered Nurse Anesthetists aim to 
provide the safest care to all their patients and in doing so they rely on current evidence-
based knowledge found through thorough research to guide their practice. The incidence 
of hypotension after spinal anesthesia can not always be prevented but the vasopressor 
used for treatment can be chosen using critical thinking and evidence-based knowledge 
found through research. 
Although the occurrence of true fetal acidosis could not be determined with the 
use of either ephedrine or phenylephrine in the reviewed studies, the incidence of a 
higher pH with phenylephrine should be taken in to consideration when choosing the best 
vasopressor. Both ephedrine and phenylephrine groups had similar efficacy for 
preventing or treating hypotension and there was no difference in clinical neonatal 
outcome as measured by Apgar scores. Nevertheless, the objective of obstetric anesthesia 
practice is to deliver the fetus in the best condition possible. The studies included 
reported on the higher incidence of a lower normal pH with ephedrine. Caution should 
also be taken with the use of ephedrine as the sole vasopressor of choice in obstetric 
anesthesia and particularly in cases where there is an already increased risk of fetal 
acidosis. 
Continuing education on the indications, dosages and side effects of both 
phenylephrine and ephedrine should be obtained prior to their use. No vasopressor alone 
shows benefit over the other but caution should be used based on their side effects. 
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Ephedrine results in lower pH values but true acidosis has not been seen and 
phenylephrine’s primary alpha agonist properties promote it’s side effect of bradycardia. 
Due to this, patients experiencing bradycardia should not be given phenylephrine as a 
vasopressor because of the risk of worsening bradycardia. Based on the incidental finding 
of nausea and vomiting associated with ephedrine use, caution should be taken with the 
use of ephedrine in patients at high risk for nausea and vomiting or those already 
experiencing such. Systematic reviews are intended to provide up to date information 
regarding the latest, safest and most effective methods of anesthesia care. This 
information can be used not only to improve the practice of existing practitioners, but 
also become incorporated in the curriculum of institutions training future CRNAs. 
 No recommendations on policy change can be made when it comes to the use of 
ephedrine and phenylephrine in choosing one over the other. Based on the conclusion of 
this systematic review, both medications are acceptable for use in practice. Caution 
should be taken with the use of ephedrine due to the outcome of lower normal pH than 
phenylephrine, especially in patients with risk of fetal acidosis. 
 Further randomized controlled trials need to be conducted with larger sample 
sizes and and including key variables aforementioned.. Through this research, 
practitioners may be able to better gauge the use of ephedrine and phenylephrine in their 
everyday practice. A separate study on the incidence of ephedrine-induced post-operative 
nausea and vomiting should be completed to determine its role in the matter. These 
studies would be essential in developing even safer and more effective protocols in 
obstetric anesthesia. 
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Appendix A-1 
Data Collection Tool 
 
Cooper, D. W., Sharma, S., Orakkan, P., & Gurung, S. (2010). Retrospective study of association between choice of vasopressor given 
during spinal anesthesia for high-risk caesarean delivery and fetal pH. International Journal of Obstetric Anesthesia, 19(1), 44-49. 
Method/Level 
of evidence & 
Major 
Variables 
Studied 
Sample/ Setting Intervention Data Analysis Results Limitations 
Retrospective 
observational 
study and 
chart review 
over a 4-year 
period from 
2000-2003 
 
Level III 
(Retrospective 
cohort study) 
 
Maternal: 
blood pressure 
Fetal: 5 min 
Apgar score, 
umbilical 
Charts reviewed 
were those in 
the 4-year 
period of 2000-
2003, women 
with high risk 
pregnancies that 
had a cesarean 
section under 
spinal 
anesthesia for 
singleton 
delivery where 
fetal umbilical 
artery and 
venous pH were 
recorded and 
these 
participants 
either received 
ephedrine 
Once women for the study 
were identified, the authors 
then reviewed the notes, 
recording maternal and 
fetal demographic and 
operative data. Blood gas 
values, taken from a 
double clamped segment of 
umbilical cord at delivery, 
5 min Apgar scores 
assessed by a midwife and 
admission to the neonatal 
unit were all recorded. 
During the period of the 
study, ephedrine was 
routinely given as 6mg 
boluses and phenylephrine 
as 100 mcg boluses, at the 
discretion of the 
anesthetist. Phenylephrine 
infusion was recommended 
Primary outcome was 
umbilical artery pH. 112 
participants per group 
would give the study an 
80% chance of detecting a 
0.03 difference in umbilical 
artery pH, at P=0.05 based 
on a standard deviation of 
0.08 for umbilical artery pH 
for non-elective C-section 
under spinal anesthesia. 
Secondary outcomes were 
the incidence of fetal 
acidosis (pH <7.20), low 5 
min Apgar score (<7) and 
admission to the neonatal 
unit. Mann-Whitney and 
Kruskal-Wallis tests were 
used for direct comparison 
The no vasopressor, ephedrine 
and phenylephrine groups were 
similar for demographic data but 
there were differences for 
diabetes (P=0.042), previous C-
section (p=0.19), pregnancy 
induced hypertension (P=0.003), 
spinal local anesthetic dose 
(P=0.006) and hypotension 
(P=0.005). The median total dose 
of ephedrine given before 
delivery was 12mg; the median 
total dose of phenylephrine in 
given before delivery was 200 
mcg. The authors were unable to 
find accurate records of the dose 
of vasopressor given by infusion. 
13% of the ephedrine group were 
given a second line vasopressor 
(median total dose 200 mcg) 
compared with 5% of the 
Low doses of 
ephedrine used, 
cofounding variables 
were not examined. 
Prematurity and labor 
may have contributed 
to the lack of 
difference between the 
vasopressor groups in 
this high risk study by 
reducing hypotension 
and therefore, 
vasopressor 
requirements. Urgent 
nature of the surgery 
for many of the high 
risk cases may also 
have reduced the 
difference between the 
groups by reducing the 
spinal delivery interval. 
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artery and 
venous pH 
values 
boluses, 
ephedrine 
infusion, 
phenylephrine 
bolus or 
phenylephrine 
infusion for low 
blood pressures 
 
No vasopressor 
n=115 
Ephedrine total 
n=122 
(Ephedrine 
bolus n=110 
Ephedrine 
infusion n= 12) 
Phenylephrine 
total n=148 
(Phenylephrine 
bolus n=51 
Phenylephrine 
infusion n=97) 
only to be given according 
to a standard protocol, 
which had been developed 
for a prospective study 
completed in 2001 at our 
hospital. Phenylephrine 
was started at 33 mcg/min 
immediately following 
spinal injection and then 
titrated aiming to keep 
systolic blood pressure 
(SBP) at baseline. The 
infusion rate was doubled 
or halved as required. The 
Max infusion rate was 67 
mcg/min. If there was 
hypotension despite the 
prophylactic infusion, 100 
mcg boluses of 
phenylephrine were given. 
There were no guidelines 
for ephedrine infusion. 
Criteria for admission to 
the neonatal unit were 
gestation <34 weeks, 
weight <1800g or poor 
condition. 
of the groups and 
subgroups. 
Forward stepwise multiple 
regression analysis was used 
to find which independent 
variables were associated 
with umbilical artery pH. 
The potential explanatory 
variables entered into the 
multiple regression analysis 
were choice of vasopressor, 
method of administration, 
time period, maternal age, 
maternal height, maternal 
weight, gestational age, fetal 
weight, previous C-section, 
spinal dose, spinal delivery 
interval, hypotension, direct 
involvement of a consultant 
obstetrician. Data were 
analyzed using SPSS 
version 12. P = <0.05 was 
regarded as statistically 
significant 
phenylephrine group (all 
ephedrine boluses, median total 
dose 9 mg) (P=0.014). There was 
no difference in umbilical artery 
pH between the three groups on 
direct comparison (P=0.21). 
Following forward stepwise 
multiple regression analysis, the 
only variable that was associated 
with altered pH was non-
reassuring fetal heart rate trace 
(P=0.71). On direct comparison 
there was no difference in the 
incidence of umbilical artery pH 
<7.20 (P=0.21), or 5 min Apgar 
score <7 (0.089), between the 
groups, but there was a 
difference in the incidence of 
admissions to the neonatal unit 
(0.040), 37% of patients in the 
phenylephrine group were 
admitted, 23% in ephedrine 
group and 33% in no vasopressor 
group. The authors observations 
for umbilical artery pH differ 
from those in low risk 
participants which show a higher 
pH with phenylephrine. 
There was no accurate 
record of maternal 
oxygen administration 
which can affect 
umbilical venous PO2. 
The ephedrine and 
phenylephrine groups 
were not matched for 
potential confounding 
variables such as time 
period of operation, 
method of vasopressor 
administration, labor, 
and bupivacaine dose. 
This could have biased 
the univariate analysis. 
Arterial pressure was 
documented by hand so 
there may have been a 
degree of selective 
recording or rounding 
up of readings. 
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Appendix A-2 
Data Collection Tool 
 
Cooper, D. W., Carpenter, M., Mowbray, P., Desira, W. R., Ryall, D. M., & Kokri, M. S. (2002). Fetal and maternal effects of 
phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. The Journal of the American Society of Anesthesiologists, 
97(6), 1582-1590. 
Method/lev
el of 
evidence & 
Major 
variables 
studied 
Sample/ 
Setting Intervention Data Analysis Results Limitations 
Randomized
/Double 
blind study  
 
Level II 
evidence 
 
Maternal: 
blood 
pressure and 
heart rate, 
Nausea and 
vomiting 
scores. 
 
Fetal: Apgar 
score, 
umbilical 
artery pH 
and venous 
pH 
 
Inclusion: 
ASA I and II 
participants 
scheduled 
for elective 
C-section 
under spinal 
anesthesia. 
Singleton 
pregnancies, 
with no fetal 
abnormalitie
s and no 
history of 
preeclampsi
a or diabetes 
mellitus. 
 
Exclusion: 
ASA >III, 
non elective 
C-sections, 
C-sections 
requiring 
Before entering the anesthesia room, the 
participants had 3 blood pressure and heart 
rate readings recorded with an automated 
oscillometer at 3 min intervals while sitting 
in bed. The lowest of the 3 readings was 
recorded as the baseline values. The highest 
nausea and vomiting score was recorded for 
30 min before the spinal (0= none, 1= nausea 
with no vomiting, 2= vomiting). participants 
were randomly allocated by envelope 
selection to one of 3 vasopressor solutions to 
maintain maternal systolic arterial pressure. 
The participants, anesthetists, nurses and 
midwives involved were all blinded to the 
patient grouping. The P group received 
phenylephrine 100mcg/ml. the E group 
received ephedrine 3mg/ml and the C group 
received a combination of phenylephrine 
50mcg/ml combined with ephedrine 
1.5mg/ml. These concentrations were based 
on unpublished pilot work performed at the 
hospital where the study took place to find 
solutions of similar potency. A third party not 
involved with the study opened an envelop 
The study was 
designed to 
have an 80% 
chance of 
detecting a 15% 
incidence of 
fetal acidosis 
(umbilical 
artery pH 
<7.20) in the 
ephedrine 
group (E 
Group) and an 
80% chance of 
detecting a 
difference of 
0.03 in the 
mean umbilical 
artery pH at 
P=0.05. The 
Kruskal-Wallis 
test was used to 
compare the 
three groups. If 
48 (n=48) participants in the phenylephrine 
group (P group), 50 (n=50) in the ephedrine 
group (E Group) and 49 (n=49) in 
combination of phenylephrine and 
ephedrine solution group (C group) were 
studied. The 3 groups were comparable for 
age, height, weight, gestation, breech 
presentation, previous c-section, delivery 
and birth weight. The groups were well 
matched for the spinal anesthetics given (P= 
0.99), the investigators collecting data 
(P=0.77) and for the uterine incision to 
delivery interval (P=0.10). 
Overall the mean systolic arterial blood 
pressure (SABP) from spinal until delivery 
was similar for all three groups as was the 
SABP over time for the 3 groups. There was 
a small but statistically significant 
difference between 20 and 25 min post-
spinal when the MAP was lower in the 
phenylephrine group than in the epidural 
and combination groups. The incidence of 
hypotension (SABP <80%) was similar for 
the 3 groups. However, there was a small 
Code had to 
be broken in 
two of the 
ephedrine 
cases due to 
hypotension 
not 
responding 
to 
ephedrine. 
All 
participants 
were healthy 
women 
undergoing 
elective C-
section 
delivery so 
extrapolatio
n to 
situations 
where fetal 
compromise 
is present or 
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general 
anesthesia, 
multiple 
fetuses, fetal 
abnormalitie
s or history 
of 
preeclampsi
a or 
diabetes. 
 
containing the code for the patient group and 
gave the investigator the relevant unlabeled 
syringe. The solution was further diluted to to 
a total of 40ml. One of 4 spinal anesthetics 
techniques was used based on provider 
preference. To avoid bias, randomization was 
stratified by using separate set of 
randomization envelopes for each of the 
standard spinal anesthetics techniques. 
Technique 1:  2.5ml of spinal hyperbaric 
0.5% bupivacaine with 20mcg of fentanyl 
given in sitting position. Technique 2: 2ml of 
spinal levobupivacaine 0.5% with 20 mcg 
fentanyl given in the sitting position before 
an epidural catheter was inserted. Technique 
3: 2ml of spinal levobupivacaine 0.5% with 
20 mcg, given in the left lateral position 
before an epidural catheter was inserted. 
Technique 4: 2.5ml of spinal levobupivacaine 
0.5% with 10 mcg of fentanyl, given in the 
left lateral position before an epidural 
catheter was inserted. The level of the spinal 
was measured 10 min post-spinal and at skin 
incision.  Target block height was T5. An 
epidural top-up, using 0.5% levobupivacaine 
was only used pre-delivery if neural blockade 
was not sufficiently high or dense with spinal 
anesthesia alone. Immediately before spinal 
anesthesia a preload of 10ml/kg of Hartmann 
solution as rapidly infused. Immediately 
following spinal injection, the infusion of IV 
vasopressor solution was started according to 
protocol. The patient was then positioned 
supine with a left lateral tilt. Systolic arterial 
pressure and heart rate were measured every 
minute using the same oscillometer as the 
baseline. The rate of the solution was 
a difference 
was found with 
the Kruskal-
Wallis test, 
pairs of groups 
were then 
compared using 
the Mann-
Whitney U test. 
The Wilcoxon 
signed-rank test 
and spearman 
rank test were 
also used to 
analyze data. 
The Wilcoxon 
signed-rank test 
was used to 
compare data 
within a group. 
P<0.05 was 
considered 
significant. 
but statistically significant differences 
between the 3 groups for the lowest SABP 
recorded and for the proportion of SABP 
readings below 80% of baseline (P=0.02). 
The lowest SABP recorded was higher in 
the P group (80% [73-88] of baseline) than 
in the E group (73% [61-87] of baseline) 
(P=0.02) but the C group (77% [69-86] of 
baseline) was not significantly different 
from the P (P=0.14) and E (P=0.25) groups. 
The proportion of SABP readings below 
80% of baseline was lower in the P group 
(0% [0-8]) (P+0.007) and in the C group 
(4% [0-10]) (P+0.04) than in the E group 
(8% [0-20]), but there was no difference 
between the P and C groups (P=0.55). from 
5 min onward the HR was higher in the E 
group than in the P and C groups. Overall 
the mean HR in the C group was lower than 
in the E group (P<0.0001) and higher than 
in the phenylephrine group (P=0.008). The 
highest HR recorded differed between the 
groups (P<0.0001): it was higher in the E 
group (137% [124-156] of baseline) than in 
the P group (115% [108-128] of baseline) 
(P<0.0001) and the C group (122% [109-
140] of baseline) (P+0.004), but there was 
no difference between the P and C groups 
(P=0.051).  Fetal acidosis was less frequent 
in the P group (1 of 48) and less frequent in 
the C group (1 of 47) than in the E group 
(10 of 48) (overall P=0.0007). There was no 
difference in the incidence of fetal acidosis 
between the P and C groups (P=0.99). 1 and 
5 min APGAR scores were good in all 3 
groups and no infant required intubation or 
admission to the special care baby unit. 
to 
emergency 
C-section 
delivery 
may not be 
valid. All 
participants 
were fluid 
preloaded 
which could 
also add to 
the high 
baseline 
blood 
pressures. 
The doses of 
ephedrine 
and 
phenylephri
ne used 
were based 
on an 
unpublished 
pilot work 
performed at 
the same 
hospital. 
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doubled or halved if the systolic arterial 
blood pressure (BP) fell below or above 0.75 
times the baseline. Phenylephrine was started 
at 33mcg/min; ephedrine was started at 
1mg/min or half the dose rate for each for the 
combination solution. The max infusion rate 
was 40ml/hr. and min rate was 1.3ml/hr. If 
more than 40ml/hr. was required 1 or 2ml 
boluses of trial solution could be given. If the 
systolic arterial pressure was above 1.25 
times the baseline the infusion was stopped 
and restarted at half the rate when the systolic 
arterial pressure was below 1.25 times the 
baseline again. The max nausea and vomiting 
score was recorded between spinal and 
delivery. At delivery one of the investigators 
obtained umbilical artery and vein blood 
samples from a segment of the umbilical cord 
double clamped before the baby’s first 
breath. No supplemental O2 was given to the 
mother prior to delivery. APGAR scores 
recorded at 1 and 5 minutes by a midwife and 
the need for tracheal intubation, ventilation or 
admission to the special care baby unit were 
recorded. 
Blood gas values were similar for the P and 
C groups. The E group had a lower 
umbilical artery pH than the P group 
(P=0.002) or the C group (P=0.009), and a 
lower umbilical vein pH than the P group 
(P=0.04) or the C group (P=0.003). There 
was no difference in the umbilical vein 
PCO2 between the groups but the E group 
had a higher umbilical artery PCO2 than the 
P group (P=0.002). Baseline N/V 
(nausea/vomiting) scores were similar for 
all 3 groups. There was no change in the P 
group from baseline N/V scores (P=0.30) 
but in the E and C group the N/V scores 
increased from baseline (E= P<0.0001) (C = 
P=0.007). The N/V scores were lower in the 
P group than in the E group (P<0.0001) or 
C group (P<0.0001) but there was no 
significant different between the E and C 
groups (P=0.09). In the E group vomiting 
(n=18) was associated with decreased HR 
and SABP and increased ephedrine doses. 
There was no difference in the block height 
at 10 min or at skin incision for the E group 
participants who vomited, compared with 
the E group participants without N/V 
(P=0.57 and P=0.36). 
The incidence of fetal acidosis and vomiting 
at cesarean delivery under spinal anesthesia 
was reduced by giving phenylephrine alone 
or in combo with ephedrine compared with 
giving ephedrine alone.  
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Appendix A-3 
Data Collection Tool 
 
Ngan Kee, W. D., Khaw, K. S., Lau, T. K., Ng, F. F., Chui, K., & Ng, K. L. (2008). Randomized double-blinded comparison of 
phenylephrine vs. ephedrine for maintaining blood pressure during spinal anesthesia for the non-elective Caesarean section. 
Anesthesia, 63(12), 1319-1326. 
Method/level 
of evidence & 
Major 
variables 
studied 
Sample/ 
Setting Intervention Data Analysis Results Limitations 
Randomized/D
ouble blind 
study using 
computer-
generated 
codes 
contained in 
opaque seal 
and 
sequentially 
numbered 
envelopes.  
 
Level II 
evidence 
 
Maternal: 
blood pressure 
and heart rate 
and Nausea 
and vomiting 
Fetal: Apgar 
score and 
umbilical 
artery blood 
204 (n=204)  
Inclusion:  
ASA I and II 
women with 
singleton 
pregnancies 
scheduled for 
non-elective 
C-section for 
which spinal 
anesthesia 
was decided 
upon for 
clinical 
reasons at any 
point in time. 
 
Exclusion:  
participants 
with pre-
existing or 
pregnancy 
induced 
hypertension, 
cardiovascula
participants were premedicated with 
0.3M Na citrate 30 ml on arrival to the 
OR. Standard monitoring included 
noninvasive BP measurement, ECG and 
pulse Oximetry. Fetal HR (heart rate) 
was monitored by external 
cardiotocography until surgical prep. No 
IV prehydration was given. Spinal 
anesthesia was induced with the patient 
in the right lateral position. After skin 
infiltration with lidocaine, a 25-gauge 
pencil point needle was inserted at what 
was estimated to be L3-4 or L4-5 
vertebral interspace and 2.0-2.2 ml of 
hyperbaric 0.5% bupivacaine (10-20 
mg) and fentanyl 15 mcg was injected 
intrathecally. The patient was then 
immediately turned to supine with a left 
lateral tilt and a rapid IV co-hydration 
with up to 2 liters of lactated ringer’s 
solution, oxygen of 6-8 L/min was 
administered by clear facemask until 
delivery. BP (blood pressure) was 
measured at 1 min intervals beginning at 
1 minute after spinal injection. 
85 participants 
(n=85) per group 
would be required 
to have a 90% 
power at the 0.05 
significance level 
to detect a 
difference 
between groups. 
Primary analysis 
was performed on 
an intention to 
treat basis and a 
secondary 
analysis was 
performed on a 
per protocol basis 
to compare only 
protocol-
compliant 
participants who 
actually required 
treatment for 
hypotension with 
a vasopressor. 
Data collection was completed over a 
2-year period. Overall 74/102 (73%) of 
participants in the P group and 74/102 
(73%) of the E group had one or more 
episodes of hypotension and required 
one or more boluses of vasopressor 
(p=0.52). The number of episodes of 
hypotension and the total volume of IV 
fluid given in each group was similar. 
The min recorded HR was lower in the 
P group vs the E group but there was 
no difference in max recorded HR or 
min and max SBP recorded. The 
number of doses of vasopressor 
required was similar between groups. 
More participants had N/V in the E 
group than the P group (13/102 
(12.7%) vs 4/102 (3.9%), P=0.02). 
There was no difference between 
groups in the primary outcome, UA pH 
(p=0.70). In the E group 2 cases had a 
UA pH <7.0 compared with no cases in 
the P group (P=0.50). the UA PO2 was 
lower in the P group vs the E group 
(Median difference 0.23 (95% CI of 
Insufficient 
amount of UA 
blood was 
obtained in 1 
patient in the P 
group and 2 
participants in 
the E group. 
Insufficient UV 
blood was 
obtained for 
analysis in 2 
participants in 
the E group. 8 
UA sample and 
1 UV sample 
was below the 
min reportable 
limit range. 
After the study 
commenced a 
study was 
published by 
Saravanan et al. 
reporting that 
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gases and 
venous blood 
gases 
 
 
r or 
cerebrovascul
ar disease, 
multiple 
gestation, 
known fetal 
abnormality 
or any 
medical 
contraindicati
ons to spinal 
anesthesia 
such as 
thrombocytop
enia or 
coagulopathy 
 
Hypotension as defined as SBP (systolic 
blood pressure) <100 mmHg. 
participants were randomized to receive 
an IV bolus of either phenylephrine 100 
mcg (group P) or ephedrine 10 mg 
(group E) immediately after each 
episode of hypotension. The doses of the 
drugs were chosen based on clinical 
experience. The upper sensory level of 
the spinal anesthesia was tested at 5 min 
after the spinal injection. Skin incision, 
uterine incision and delivery were all 
recorded. Vasopressor protocol was 
continued until the time of uterine 
incision. The total dose of vasopressor 
given up to time of uterine decision, the 
total volume of IV fluid given and any 
incidence of nausea or vomiting and the 
number of episodes of hypotension was 
recorded. Bradycardia was defined as 
HR <50 bpm. The attending pediatrician 
assessed APGAR scores at 1 and 5 min 
after delivery. We recorded the number 
of neonates admitted to the special care 
baby unit and neonatal intensive care 
unit and the duration of stays. Umbilical 
arterial (UA) and umbilical venous (UV) 
blood samples from double-clamped 
segments of umbilical cord were 
obtained. 
Univariate 
intergroup 
comparisons were 
made using the 
unpaired student’s 
t-test or the 
Mann-Whitney U-
test as 
appropriate. 
Nominal data 
were compared 
using the Chi-
Square test or 
Fisher’s exact 
test. Analyses 
were made using 
SPSS version 
10.1.4 and 
confidence 
interval Analysis 
2.0.0. Values of 
p<0.05 were 
considered 
statistically 
significant. 
difference 0.20-0.45) p=0.032) and UV 
PO2 was lower in the P group vs the E 
group (Median difference 0.39 (95% CI 
of difference 0.08-0.70) P=0.012). 
However, there was no difference 
between groups in UA or UV oxygen 
content.  There was no difference 
between groups in the clinical outcome 
of the neonates. One neonate in the E 
group had an APGAR score <7 at 1 
min and 5 min and one neonate in the P 
group had an APGAR score <7 at 1 
min; all other APGAR score were >7. 
17 neonates (17%) in the P group and 
21 (21%) neonates in the E group were 
admitted to the special care baby unit 
(P=0.045). There was no difference in 
the duration of stay between groups. In 
the ephedrine group UA lactate was 
higher and UV lactate was higher, UA 
pO2 and UV PO2 were lower in the P 
group although O2 content was similar. 
More participants had nausea or 
vomiting in the E group but there was 
no other difference in clinical outcome. 
Both Phenylephrine and Ephedrine are 
suitable vasopressors for use in non-
elective C-sections. 
the potency 
ratio of 
phenylephrine: 
ephedrine was 
approximately 
80:1 
(Phenylephrine 
100 mcg = 
ephedrine 8mg) 
when the drugs 
were given by 
infusion 
therefore the 
doses used in 
this study were 
not equipotent. 
There was a 
relatively small 
amount of 
vasopressors 
used in this 
study and that 
may explain the 
findings to be 
not lower in the 
E group as 
predicted in 
multiple 
previous 
studies. 
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Appendix A-4 
Data Collection Tool 
 
Prakash, S., Pramanik, V., Chellani, H., Salhan, S., & Gogia, A. R. (2010). Maternal and neonatal effects of bolus administration of 
ephedrine and phenylephrine during spinal anesthesia for caesarean delivery: a randomized study. International Journal of Obstetric 
Anesthesia, 19(1), 24-30. 
Method/level 
of evidence 
& 
Major 
variables 
studied 
Sample/ 
Setting 
Intervention Data Analysis Results Limitations 
Randomized/
Double blind 
study with 
computer 
generated 
number 
allocation 
 
Level II 
evidence 
 
Maternal: 
blood 
pressure and 
heart rate 
Fetal: Apgar 
score and 
umbilical 
artery pH and 
venous pH 
 
 
 
 
A total of 60 
women who 
developed 
hypotension 
participated. 
n=30 in the 
ephedrine 
group, n=30 in 
the 
Phenylephrine 
group 
 
Inclusion: 
ASA 1 women 
with singleton 
pregnancies 
scheduled for 
elective 
caesarean 
delivery under 
spinal 
anesthesia 
were recruited. 
All women received ranitidine and metoclopramide 
for antacid prophylaxis. Standard monitoring with 
on-invasive arterial pressure, electrocardiography 
and pulse oximetry was established. 
Women rested undisturbed in the supine position 
with left uterine displacement for 5 min following 
which baseline blood pressure and heart rate were 
calculated as the mean of three successive readings 
measured 1 min apart. Each patient also received a 
10ml/kg IV infusion of Lactated Ringers solution 
over 15-20 min before spinal anesthesia.  
With participants in the left lateral position, 2ml 
0.5% Hyperbaric Bupivacaine was injected 
intrathecally at L3-4 via a 25 gauge Quincke needle. 
participants were then immediately turned supine 
and positioned with left uterine displacement. Heart 
rate and blood pressure were recorded at 1 min 
intervals from the time of induction of spinal 
anesthesia until delivery. Oxygen 6L/min via face 
mask was delivered until delivery. Sensory block to 
the T5 dermatome was considered adequate for 
surgery. 
A total of 23 
women per 
group would 
have a 90% 
power at the 5% 
significance 
level to detect a 
difference in 
umbilical 
arterial pH of 
0.03 between 
groups. To 
allow for 
potential drop-
outs a total of 
30 participants 
per group with a 
SBP <80% of 
baseline were 
recruited 
 
Descripting 
statistics were 
calculated for 
The two groups were 
comparable in age, weight, 
height, baseline hemodynamic 
data and dermatomal sensory 
levels. There were no 
significant differences in the 
mean induction to delivery or 
uterine to delivery intervals 
between the two groups. 
Although not significant, 
induction to delivery times 
varied, hemodynamic changes 
were compared up to 20 min 
after induction of spinal 
anesthesia, by which time 59 
out of 60 women had 
delivered.  The mean change 
in systolic pressure was 
comparable in the two groups 
with the minimum being 100 
in the E group and 93 in the P 
group (P=0.114) except at 8 
minutes where E group was 
lower (P=0.004). The fall in 
Sample size 
was small. All 
participants 
were healthy 
women 
undergoing 
elective C-
section 
delivery so 
extrapolation 
to situations 
where fetal 
compromise is 
present or to 
emergency C-
section 
delivery may 
not be valid. 
There was a 
high baseline 
blood pressure 
than could of 
been due to the 
setting where 
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 Exclusion: 
Women with 
pre-existing or 
pregnancy 
induced 
hypertension, 
diabetes 
mellitus, 
known 
cardiovascular 
or 
cerebrovascula
r disease, fetal 
abnormality, 
or 
contraindicatio
n to spinal 
anesthesia. 
 
 
Women were randomly assigned to received one of 
two vasopressor solutions whenever systolic pressure 
decreased to 80% of baseline or less. 
participants were divided into 2 groups: P group 
(phenylephrine) and E group (ephedrine). Group E 
received 1ml bolus of ephedrine 6mg/ml, group P 
received a 1 ml bolus of phenylephrine 100 mcg/ml. 
Additional boluses were administered if the systolic 
pressure remained at or below 80% of baseline. 
Atropine was administered in 0.3mg increments 
whenever bradycardia was associated with systolic 
pressure less than baseline or if the heart rate was 
<45 bpm The incidence of maternal tachycardia 
(>100 bpm) and reactive hypertension (>20% of 
baseline) were recorded after the administration of 
either ephedrine in group E or phenylephrine in 
group P. The number of vasopressor doses required, 
total doses of vasopressor administered, time of first 
administration of vasopressor, requirement for 
atropine and its relation to vasopressor 
administration were noted. The time of induction of 
spinal anesthesia, uterine incision and delivery were 
recorded. After delivery oxytocin 5 units was given 
by slow IV injection followed by a 10-unit infusion. 
The incidence of nausea and vomiting was recorded. 
Arterial and venous blood samples were obtained 
from a double clamped segment of the umbilical 
cord and analyzed within 10 minutes. Apgar scores 
at 1, 5 and 10 minutes were determined by the 
attending pediatrician who was unaware of group 
assignment. Time and onset of sustained rhythmic 
respiration was noted. 
continuous 
variables as 
mean and 
standard 
deviation and 
for categorical 
variables as 
frequency of 
distribution and 
percentage. To 
assess trend 
within 
variables, two-
way analysis of 
variance was 
used. P < 0.05 
was regarded as 
statistically 
significant. 
SPSS 14.0 for 
Windows 
statistical 
software was 
used for 
analysis. 
 
 
heart rate below mean baseline 
in group P was significantly 
greater than in group E (20± 
10 vs 6± 0.6, P<0.001). In all 
cases, bradycardia developed 
following phenylephrine 
administration. Birth weight 
and Apgar scores at 1 
(p=0.739), 5 (p=0.128) and 10 
min (p=0.611) were 
comparable in the two groups. 
No neonate had an Apgar 
score <7 at any time. Time to 
onset of rhythmic respiration 
was <90s in all cases. No 
neonate required tracheal 
intubation or admission to the 
neonatal intensive care unit. 
No umbilical artery pH was 
less than 7.20. Umbilical 
artery and venous pH were 
significantly lower in group E 
than in group P (p=0.01 and 
P=0.002) 
Results showed the 100 mcg 
bolus doses of phenylephrine 
are as effective as 6 mg bolus 
doses of ephedrine in the 
treatment of hypotension 
following spinal anesthesia in 
term parturients undergoing c-
section delivery.  Neonates of 
women treated with 
phenylephrine had higher 
umbilical cord pH though true 
fetal acidosis was not seen in 
any neonate. 
the baseline 
was taken that 
being the OR 
which is a high 
stress 
environment. 
All 
participants 
were fluid 
preloaded 
which could 
also add to the 
high baseline 
blood 
pressures. The 
doses of 
ephedrine and 
phenylephrine 
used were 
based on 
clinical 
experience of 
the authors 
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Appendix A-5 
Data Collection Tool 
Mercier, F. J., Augè, M., Hoffmann, C., Fischer, C., & Le Gouez, A. (2013). Maternal hypotension during spinal anesthesia for 
caesarean delivery. Minerva Anestesiol, 79(1), 62-73. 
Method/
level of 
evidence 
& 
Major 
variable
s studied 
Sample/ 
Setting Intervention Data Analysis Results Limitations 
Randomi
zed 
double-
blind 
study 
using a 
random 
table 
with 
stratificat
ion to 
allocate 
participa
nts to 
each 
group 
 
Level II 
evidence 
 
Maternal
: blood 
pressure 
42 parturients 
(n=42) 
scheduled for 
Caesarean 
section (C-
section) 
delivery 
using spinal 
anesthesia. 
 
Inclusion: age 
18-years or 
older, weight 
90Kg or less, 
height 152cm 
or greater, 
ASA I or II, 
and term 
singleton 
pregnancy. 
Exclusion: 
parturients 
with 
Participants were fasted overnight and were given 
30 ml of sodium citrate. Oxygen was administered 
to all participants via nasal cannula. Standard 
monitors included electrocardiogram, noninvasive 
BP device and pulse oximetry. After an 
intravenous (IV) preload of 15ml/kg of Lactated 
Ringer’s Solution (LR) was given, spinal 
anesthesia was performed at the L2-L3 or L3-L4 
interspace with the patient sitting, using a 9 cm 25 
gauge whitacre spinal needle. 11mg of hyperbaric 
0.5% Bupivacaine, 2.5 mcg Sufentanil and 0.1 mg 
morphine was injected through the spinal needle. 
Participants were then immediately placed in the 
recumbent position with left uterine displacement. 
A prophylactic vasopressor IV infusion was started 
at the end of spinal injection. participants received 
either 2mg/min ephedrine plus 10 mcg/min 
phenylephrine (E+P group) or 2mg/min ephedrine 
alone (E group). Study solutions were prepared by 
an anesthesiologist or a nurse anesthetist not 
involved in the participant’s care and according to 
the group indicated in a numbered sealed 
envelope. One of the investigators was present 
Data was expressed 
as mean ± SD 
unless stated 
otherwise. Groups 
were compared for 
single parametric, 
ordinal and 
nominal variables 
suing unpaired 
student t test, the 
Mann-Whitney U 
test, and Fisher 
exact test, 
respectively. 
Hemodynamic 
values over time 
were compared 
using analysis of 
variance for 
repeated measures, 
followed by 
Dunnett tests. A 
forward stepwise 
Participants characteristics, 
gestational age, neonatal weight, 
upper sensory level of anesthesia at 
20 min and time intervals from 
spinal anesthesia to incision, from 
spinal anesthesia to delivery and 
from uterine incision to delivery 
were comparable between the two 
groups. Baseline SBP and maternal 
HR were also comparable between 
the groups. 
The incidence of hypotension was 
halved in the E+P (37%) group 
when compared with the E (75%) 
group (P=0.02). SBP values after 
onset of spinal anesthesia were not 
significantly different between the 
two groups. Minimal SBP values 
before delivery were lower in the E 
group but the difference was no 
statistically significant (P=0.08). 
Hypotensive episodes were brief 
and of similar cumulative duration 
Phenylephrine 
alone group 
studied would 
have allowed 
for a broader 
knowledge 
base. 
Hypotension 
was found to 
be very 
frequent in 
this study and 
more 
prophylaxis 
should be 
used. 
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Fetal: 
Umbilica
l cord 
blood pH 
and 
Apgar 
scores 
pregnancy-
induced 
hypertension, 
cardiac 
disease, 
diabetes, or 
fetal 
complications
, and those in 
labor 
 
during the study period to confirm comparability 
of routine procedures. The primary outcome 
variable was the incidence of hypotension, defined 
as a systolic blood pressure (SBP) <100 mmHg 
and less than 80% of baseline before delivery. 
Baseline SBP and maternal heart rate (HR) were 
determined by the average of 3 measurements 
obtained before preloading with LR. After spinal 
injection SBP and maternal HR were measured 
every minute for 10 min and every 2 min there 
after until delivery. A predefined algorithm was 
used to adjust the syringe rate according to SBP as 
follows: 
-maintain rate if SBP within 90-105% of baseline 
-Rate halved if SBP 105-120% of baseline 
-Stop if SBP >120% of baseline 
-Rate doubled if SBP 80-90% of baseline 
-SBP <100 mmHg and <80% of baseline treated 
with 6mg ephedrine bolus doses repeated as 
needed. 
For each subject, a min and max SBP and HR 
were recorded before delivery. A back up plan 
designed to treat several critical situations allowed 
anesthesiologist to administer epinephrine, 
addition phenylephrine or atropine as needed. The 
upper level of sensory changes was determined 
using an alcohol swab 20 min after spinal 
injection. Additional data collection included time 
intervals from spinal anesthesia to incision, from 
spinal anesthesia to delivery, and from uterine 
incision to delivery, the dose of vasopressor 
infused until delivery, venous and arterial 
umbilical cord pH values, neonatal Apgar scores 
and neonatal weight. 
regression analysis 
was performed to 
determine the 
association 
between venous or 
arterial umbilical 
blood pH with the 
following five 
variables: duration 
of hypotension, 
total ephedrine 
dose, time interval 
from spinal 
anesthesia to skin 
incision, time from 
spinal anesthesia to 
delivery, and time 
from uterine 
incision to 
delivery. P <0.05 
was considered 
significant. Sample 
size calculations 
indicated that 
including 37 
participants in the 
study would result 
in an 80% power to 
detect a decrease 
from 75 to 37.5% 
in the incidence of 
hypotension at a 
significance level 
of 0.05 
in both groups. Max SBP and Min 
heart rate were also comparable. 
Max heart rate before delivery was 
15 bpm higher in the E group than 
in the E + P group (P=0.02). 
Maternal heart rate after onset of 
spinal anesthesia was significantly 
increased in the E group from 3 to 6 
min after spinal anesthesia (P<0.05) 
and remained unchanged in the E+P 
group. Significantly more ephedrine 
was infused and supplementation 
given in the E group. Umbilical 
venous and arterial pH values were 
significantly higher in the E+P 
group (7.24) than in the E group 
(7.19) (P=0.05).  
The incidence of arterial pH <7.20 
was 31% higher in the E+P group 
and 63% in the E group (P=0.09). 
However, Apgar scores at 1 and 5 
min were similar in both groups 
(p=0.7) and were never less than 7. 
Low venous and arterial pH values 
were associated only with the E 
group assignment and spinal 
anesthesia to delivery times longer 
than 33 min. 
Compared with ephedrine alone 
ephedrine plus phenylephrine 
infusions decreased the incidence of 
hypotension by approx.  50%, 
abolished maternal tachycardia, and 
improved venous and arterial pH. 
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Appendix A-6 
Data Collection Tool 
Moslemi, F., & Rasooli, S. (2015). Comparison of prophylactic infusion of phenylephrine with ephedrine for prevention of 
hypotension in elective cesarean section under spinal anesthesia: a randomized clinical trial. Iranian Journal of Medical Sciences, 
40(1), 19. 
Method/level of 
evidence & 
Major variables 
studied 
Sample/ 
Setting Intervention 
Data 
Analysis Results Limitations 
Randomized/Double 
blind study using a 
table of random 
numbers and a 
computer generated 
randomization list.  
 
Level II evidence 
 
Maternal: blood 
pressure and heart 
rate  
Fetal: Apgar score 
and umbilical artery 
blood gases 
 
 
90 women 
(n=90) for 
elective c-
section under 
spinal 
anesthesia were 
recruited. 
 
Inclusion: 
healthy 
pregnant 
women with 
gestational age 
of 36 weeks or 
higher and non-
emergency c-
section 
Exclusion: <36 
weeks of 
gestation, 
emergency c-
section, high 
risk 
pregnancies 
(multiple 
participants were assigned to 3 different 
groups: phenylephrine (group Ph), 
ephedrine (group E) and placebo (group P). 
Upon arrival to the OR all participants were 
monitored for basal vital signs (HR, SBP, 
DBP, and SaO2). Prior to spinal anesthesia 
all participants received a 500 ml 
crystalloid bolus. Infusion of study drugs 
were: group Ph received 450 mcg of 
phenylephrine in 250 ml, group E received 
45 mg of ephedrine in 250 ml and group P 
received an infusion of only 250 ml normal 
saline. All solutions were label with 
numerical codes. The nurses that infused 
the solutions and monitored the vital signs 
were blinded to the solutions. The 
participants then received spinal anesthesia 
by an anesthesiologist in the sitting position 
from L4/5 or L3/4 inter-vertebral spaces 
with 2.5 ml of Bupivacaine 0.5% (12.5mg) 
and 2.5 mcg of Sufentanil. Immediately 
after spinal placement all participants were 
positioned in the supine position with left 
uterine displacement. BP (blood pressure) 
was controlled every 2 minutes until 
Data was 
analyzed 
using a one-
way 
ANOVA for 
quantitative 
variables and 
Fishers exact 
probability 
tests and chi-
square for 
qualitative 
variables and 
associations. 
Multiple 
comparisons 
were tested 
by post-hoc 
with Turkey 
technique. 
Normal 
distributions 
of data were 
evaluated by 
Kolmogorov-
In total 83 participants (n=83) were 
studied: 30 women in group Ph 
(n=30), 27 in group E (n=27) and 26 
in group P (n-26). There was no 
significant difference in 
demographic data. Indications for c-
section were: repeated c-section 
(n=53), other indications (n=25) and 
patient preference (n=4). 
There was no significant difference 
between the 3 groups in basal SBP 
(systolic blood pressure), how ever 
SBP after anesthesia every 2 and 
every 5 minutes were different 
(P>0.050) in the Ph and P groups. 
There was no significant difference 
between groups for HR (heart rate) 
except for the 1st 3 measurements of 
every 5 minutes (P=0.006). 38 
participants in all groups had severe 
hypotension and needed additional 
vasopressor therapy: group Ph=10, 
group E-15, group P=20. There was 
a significant difference between 
group Ph and groups E and P. 
Sample size 
was small. 
All 
participants 
were healthy 
women 
undergoing 
elective C-
section 
delivery so 
extrapolation 
to situations 
where fetal 
compromise 
is present or 
to emergency 
C-section 
delivery may 
not be valid. 
All 
participants 
were fluid 
preloaded 
which could 
also add to 
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gestations, 
intrauterine 
growth 
retardation, 
preeclampsia, 
maternal 
cardiovascular 
or pulmonary 
diseases), any 
contraindication 
of spinal 
anesthesia 
(patient refusal, 
coagulopathy, 
hemorrhage or 
hypovolemic 
shock) and 
unexpected 
events during 
surgery such a 
hemorrhage or 
sensory block 
level higher or 
lower than T4-
T5 after spinal 
anesthesia 
 
 
delivery and then every 5 minutes 
throughout anesthesia as were HR (heart 
rate) and SaO2 (oxygen saturation). 
Sensory block was monitored to obtain a 
T4-T5 level of anesthesia. After delivery 
and clamping of the umbilical cord, 1ml of 
blood was drawn from the umbilical artery 
for neonatal blood gas analysis. Any 
decrease in BP of about 20% from baseline 
was treated with 50-100 mcg phenylephrine 
in pH group or 5-10 mg ephedrine in E and 
P groups. This was repeated as required. 
These drugs were prepared in numerical 
labeled syringes and were given to the 
nurses blindly. They were instructed to 
administer 1ml of that drug solution if 
hypotension was greater than 20% of 
baseline (1ml of phenylephrine was 50mcg 
and 1ml of ephedrine was 5mg). HR and 
rhythm were monitored with ECG and any 
change from normal (PVC, tachycardia, 
bradycardia) were recorded and treated as 
needed. The incidence and degree of 
hypotension, number of vasopressor 
therapy and the total dose of injected 
vasopressor in each group were measured 
and recorded. 1min and 5 min APGAR 
scores were recorded as well as umbilical 
artery blood gas analysis. 
Smirnov 
normality 
test. Analysis 
was 
performed 
using SPSS 
16.0 
program. 
Statistical 
results were 
considered 
significant 
when 
P<0.05. 
Additional doses required for the 
treatment of hypotension was higher 
in groups E (65.2%, n=15) and P 
(80%, n=20) than in group Ph 
(28.57%, n=10). Overall bradycardia 
was more significant in the 
phenylephrine group and ephedrine 
group than the placebo group 
(P<0.001). There was no significant 
difference in 1 min APGAR scores 
between the groups. There was a 
significant difference in the 5 min 
APGAR scores which was better 
with group Ph and E rather than 
group P (P=0.002). UA (umbilical 
artery) blood gas analysis showed a 
significant difference in pH and 
PCO2 between Ph and P groups. 2 
neonates in the Ph group, 7 in the E 
group and 5 in the P group had 
acidosis. Acidosis was significantly 
lower in phenylephrine group 
(P=0.043) 
 
Overall results showed that women 
who underwent spinal anesthesia for 
elective c-section, SBPs and 
neonatal 
 
 
 UA pH were best maintained with a 
prophylactic infusion of 
phenylephrine compared with those 
who did not receive it and even 
better than those who received 
prophylactic ephedrine. 
the high 
baseline 
blood 
pressures. 
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Appendix B-1 
CASE worksheet 
 
Cooper, D. W., Sharma, S., Orakkan, P., & Gurung, S. (2010). Retrospective study of 
association between choice of vasopressor given during spinal anesthesia for high-risk 
caesarean delivery and fetal pH. International Journal of Obstetric Anesthesia, 19(1), 44-
49. 
 
 
 
 
 
 
 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
No	-	The	individual	authors	are	listed	but	their	
credentialing	is	not	listed.	Affiliation	is	listed.	
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Retrospective	observational/chart	review	
study	was	performed.	Protocol	used	in	reviewing	
charts	was	clearly	stated.	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 No-	The	recommendations	are	from	2010	so	not	
within	2	years	therefore	not	updated	or	current	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix B-2 
CASE worksheet 
 
Cooper, D. W., Carpenter, M., Mowbray, P., Desira, W. R., Ryall, D. M., & Kokri, M. S. 
(2002). Fetal and maternal effects of phenylephrine and ephedrine during spinal 
anesthesia for cesarean delivery. The Journal of the American Society of 
Anesthesiologists, 97(6), 1582-1590. 
 
 
 
 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Yes	-	The	individual	authors	are	listed	with	their	
credentialing	as	well	as	affiliations.		
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Randomized	double-blinded	study	–	stated	
that	randomization	was	performed	by	randomly	
allocating	patients	by	envelop	selection	to	one	of	
three	groups	all	participants	and	investigators	
were	blinded	to	the	group,	unlabeled	syringes	
were	used.	A	third	party	not	involved	in	the	study	
opened	the	envelop	and	handed	the	appropriate	
medication	to	the	investigator.	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 No-	The	recommendations	are	from	2002	so	not	
within	2	years	therefore	not	updated	or	current	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix B-3 
CASE worksheet 
 
Ngan Kee, W. D., Khaw, K. S., Lau, T. K., Ng, F. F., Chui, K., & Ng, K. L. (2008). 
Randomized double-blinded comparison of phenylephrine vs. ephedrine for maintaining 
blood pressure during spinal anesthesia for the non-elective Caesarean section. 
Anesthesia, 63(12), 1319-1326. 
 
 
 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Not	completely-	Although	the	individual	authors	
are	listed	their	credentialing	is	not	listed	but	their	
affiliations	are.	The	process	to	become	in	author	
is	also	not	described.	
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Randomized	double-blinded	study	–	stated	
that	randomization	was	performed	using	
computer	generated	codes	contained	in	opaque,	
sealed	and	sequentially	numbered	envelops	as	
well	as	medications	prepared	in	identical	syringes	
but	someone	not	involved	in	the	study	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 No-	The	recommendations	are	from	2008	so	not	
within	2	years	therefore	not	updated	or	current	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix B-4 
CASE worksheet 
 
Prakash, S., Pramanik, V., Chellani, H., Salhan, S., & Gogia, A. R. (2010). Maternal and 
neonatal effects of bolus administration of ephedrine and phenylephrine during spinal 
anesthesia for caesarean delivery: a randomized study. International Journal of Obstetric 
Anesthesia, 19(1), 24-30. 
 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Not	completely	-	The	individual	authors	are	listed	
but	their	credentialing	is	not	listed.	Affiliation	is	
listed.		
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Randomized	double-blinded	study	–	stated	
that	randomization	was	performed	by	computer	
generated	number	allocation,	identical	syringes	
prepared	by	someone	not	involved	with	data	
collection.	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 No-	The	recommendations	are	from	2009	so	not	
within	2	years	therefore	not	updated	or	current	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix B-5 
CASE worksheet 
 
 
Mercier, F. J., Augè, M., Hoffmann, C., Fischer, C., & Le Gouez, A. (2013). Maternal 
hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiol, 79(1), 
62-73. 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Yes	-	The	individual	authors	are	listed	with	their	
credentialing	and	affiliations.		
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Randomized	double-blinded	study	–	stated	
that	randomization	was	performed	by	using	
numbered,	sealed,	opaque	envelopes	ensuring	
both	the	patient	and	investigators	were	blinded	
to	group	assignment	and	study	solutions	were	
prepared	by	those	not	involved	in	the	patients	
care	and	according	to	the	group	indicated	by	the	
envelope.	There	was	an	investigator	present	
during	the	study	period	to	confirm	comparability	
and	routine	procedures.		
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 No-	The	recommendations	are	from	2001	so	not	
within	2	years	therefore	not	updated	or	current	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix B-6 
CASE worksheet 
 
Moslemi, F., & Rasooli, S. (2015). Comparison of prophylactic infusion of phenylephrine 
with ephedrine for prevention of hypotension in elective cesarean section under spinal 
anesthesia: a randomized clinical trial. Iranian Journal of Medical Sciences, 40(1), 19. 
 
 
 
 
 
Critical	Appraisal	for	Summaries	of	Evidence	(CASE)	Worksheet	
*Numbers	in	evaluation	correspond	with	those	assigned	to	articles	in	data	extrapolation	chart*	
Questions	 Evaluation	
Summary	Topic	
1. Is	the	summary	specific	in	scope	and	
application?	
Yes-		The	aim	of	the	study	is	clearly	stated	as	well	
as	the	patients	that	the	summary	applies	to	are	
well	described	
Summary	Methods	
2. Is	the	authorship	of	the	summary	
transparent?	
Yes	-	The	individual	authors	are	listed	with	their	
credentialing	as	well	as	affiliations.		
3. Are	the	reviewer(s)/editor(s)	of	the	
summary	transparent?	
No-	It	is	not	clearly	stated	that	the	summary	has	
been	edited	and	reviewed	
4. Are	the	research	methods	transparent	
and	comprehensive?	
Yes-	The	inclusion	and	exclusion	criteria	is	clearly	
stated.	A	protocol	for	the	study	was	Cleary	stated	
and	followed.	
5. Is	the	evidence	grading	system	
transparent	and	translatable?		
Yes-	Randomized	clinical	trial	–	stated	that	
randomization	was	performed	using	a	table	of	
random	numbers	and	computer	generated	
randomization	list	
Summary	Content	
6. Are	the	recommendations	clear?	 Yes-	recommendations	are	clearly	stated	and	
multiple	options	for	treatment	are	provided	
7. Are	the	recommendations	appropriately	
cited?	
Yes-	recommendations	are	appropriately	cited		
8. Are	the	recommendations	current?	 Yes-	The	recommendations	are	from	2015,	they	
are	current.	
9. Is	the	summary	unbiased?	 Unable	to	appropriately	assess	if	there	is	a	
conflict	of	interest	between	the	
recommendations	of	the	summary	and	the	
sponsor	for	any	author		
Summary	Application		
10. Can	this	summary	be	applied	to	your	
patient(s)?	
Yes-	This	evidence	and	setting	applies	to	my	
population	and	can	be	translated	to	any	patient	
within	the	same	population	and	setting.	
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Appendix C 
 
Descriptive Data Synthesis 
 
Study 
Oxygen 
supplementation 
Used 
Intravenous 
Fluid 
Prehydration 
ASA 
Classification/
patient 
characteristics 
Hypotension 
incidence 
after spinal 
Anesthesia 
Spinal 
Solution 
and 
Technique 
Umbilical 
Artery pH  
Apgar 
scores 
N/V during 
case 
Other 
important 
findings 
Cooper 
et al., 
2010 
Not reported Not reported High risk 
singleton 
pregnant 
patients 
SBP <90 
mmHg: No 
vasopressor 
group 6.1%, 
group E 17% 
and group P 
20% 
(P=0.005) 
 
No detail but 
reported to 
be non 
consistent 
On direct 
comparison 
there was 
no 
difference 
in the 
incidence of 
umbilical 
artery pH 
<7.20 
(P=0.21), 
On direct 
comparis
on there 
was no 
difference 
in 5 min 
Apgar 
score <7 
(0.089), 
 Following 
forward 
stepwise 
multiple 
regression 
analysis, 
the only 
variable 
that was 
associated 
with 
altered pH 
was non-
reassuring 
fetal heart 
rate trace 
(P=0.71). 
Cooper 
et al., 
2002 
No supplemental 
O2 was given to 
the mother prior 
to delivery. 
Immediately 
before spinal 
anesthesia a 
preload of 
10ml/kg of 
Hartmann 
solution as 
rapidly 
infused. 
ASA I and II 
participants 
scheduled for 
elective C-
section under 
spinal 
anesthesia. 
Singleton 
pregnancies, 
with no fetal 
abnormalities 
The lowest 
SABP 
recorded was 
higher in the 
P group (80% 
[73-88] of 
baseline) than 
in the E 
group (73% 
[61-87] of 
baseline) 
4 different 
spinal 
anesthetic 
solutions/tec
hniques 
were used 
based on 
provider 
presence  
To avoid 
bias, 
Fetal 
acidosis 
was less 
frequent in 
the P group 
(1 of 48) 
and less 
frequent in 
the C group 
(1 of 47) 
than in the 
1 and 5 
min 
APGAR 
scores 
were 
good in 
all 3 
groups 
Baseline N/V 
(nausea/vomi
ting) scores 
were similar 
for all 3 
groups. There 
was no 
change in the 
P group from 
baseline N/V 
scores 
 
 
	
70	
and no history 
of preeclampsia 
or diabetes 
mellitus. 
(P=0.02) but 
the C group 
(77% [69-86] 
of baseline) 
was not 
significantly 
different from 
the P 
(P=0.14) and 
E (P=0.25) 
groups. The 
proportion of 
SABP 
readings 
below 80% of 
baseline was 
lower in the P 
group (0% [0-
8]) (P+0.007) 
and in the C 
group (4% [0-
10]) (P+0.04) 
than in the E 
group (8% [0-
20]), but 
there was no 
difference 
between the P 
and C groups 
(P=0.55). 
randomizatio
n was 
stratified by 
using 
separate set 
of 
randomizatio
n envelopes 
for each of 
the standard 
spinal 
anesthetics 
techniques. 
E group (10 
of 48) 
(overall 
P=0.0007). 
There was 
no 
difference 
in the 
incidence of 
fetal 
acidosis 
between the 
P and C 
groups 
(P=0.99). 
Blood gas 
values were 
similar for 
the P and C 
groups. The 
E group had 
a lower 
umbilical 
artery pH 
than the P 
group 
(P=0.002) 
or the C 
group 
(P=0.009), 
and a lower 
umbilical 
vein pH 
than the P 
group 
(P=0.04) or 
(P=0.30) but 
in the E and 
C group the 
N/V scores 
increased 
from baseline 
(E= 
P<0.0001) (C 
= P=0.007). 
The N/V 
scores were 
lower in the P 
group than in 
the E group 
(P<0.0001) 
or C group 
(P<0.0001) 
but there was 
no significant 
different 
between the 
E and C 
groups 
(P=0.09). In 
the E group 
vomiting 
(n=18) was 
associated 
with 
decreased HR 
and SABP 
and increased 
ephedrine 
doses. 
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the C group 
(P=0.003). 
Ngan 
Kee, et 
al., 
2008 
After spinal 
administration and 
patient positioned 
supine oxygen of 
6-8 L/min was 
administered by 
clear facemask 
until delivery 
No IV 
prehydration 
was given  
 
After spinal 
administration 
and patient 
positioned 
supine a rapid 
IV co-
hydration with 
up to 2 liters of 
lactated 
ringer’s 
solution was 
given. 
ASA I and II 
women with 
singleton 
pregnancies 
scheduled for 
non-elective C-
section for 
which spinal 
anesthesia was 
decided upon 
for clinical 
reasons at any 
point in time. 
 
Overall 
74/102 (73%) 
of 
participants 
in the P group 
and 74/102 
(73%) of the 
E group had 
one or more 
episodes of 
hypotension 
(P=0.52) and 
required one 
or more 
boluses of 
vasopressor. 
Spinal 
anesthesia 
was induced 
with the 
patient in the 
right lateral 
position. 
After skin 
infiltration 
with 
lidocaine, a 
25-gauge 
pencil point 
needle was 
inserted at 
what was 
estimated to 
be L3-4 or 
L4-5 
vertebral 
interspace 
and 2.0-2.2 
ml of 
hyperbaric 
0.5% 
bupivacaine 
(10-20 mg) 
and fentanyl 
15 mcg was 
injected 
intrathecally. 
The 
There was 
no 
difference 
between 
groups in 
the primary 
outcome, 
UA pH 
(P=0.70). In 
the E group 
2 cases had 
a UA pH 
<7.0 
compared 
with no 
cases in the 
P group 
(P=0.50). 
One 
neonate 
in the E 
group had 
an 
APGAR 
score <7 
at 1 min 
and 5 min 
and one 
neonate 
in the P 
group had 
an 
APGAR 
score <7 
at 1 min; 
all other 
APGAR 
score 
were >7. 
More 
participants 
had N/V in 
the E group 
than the P 
group 
(13/102 
(12.7%) vs 
4/102 (3.9%), 
P=0.02). 
 
Prakash 
et al., 
2010 
Oxygen 6L/min 
via face mask was 
delivered after 
Each patient 
received a 
10ml/kg IV 
ASA 1 women 
with singleton 
pregnancies 
The mean 
change in 
systolic 
With 
participants 
in the left 
No 
umbilical 
artery pH 
Apgar 
scores at 
1 
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spinal 
administration and 
positioning  until 
delivery 
infusion of 
Lactated 
Ringers 
solution over 
15-20 min 
before spinal 
anesthesia. 
scheduled for 
elective 
caesarean 
delivery under 
spinal 
anesthesia 
pressure was 
comparable 
in the two 
groups with 
the minimum 
being 100 in 
the E group 
and 93 in the 
P group 
(P=0.114) 
except at 8 
minutes  
where E 
group was 
lower 
(P=0.004). 
lateral 
position, 2ml 
0.5% 
Hyperbaric 
Bupivacaine 
was injected 
intrathecally 
at L3-4 via a 
25 gauge 
Quincke 
needle. 
was less 
than 7.20. 
Umbilical 
artery and 
venous pH 
were 
significantly 
lower in 
group E 
than in 
group P 
(p=0.01 and 
P=0.002) 
but never 
reached true 
acidosis 
(p=0.739)
, 5 
(p=0.128) 
and 10 
min 
(p=0.611) 
were 
comparab
le in the 
two 
groups. 
No 
neonate 
had an 
Apgar 
score <7 
at any 
time. 
Mercier 
et al., 
2013 
Oxygen was 
administered to all 
participants via 
nasal cannula of 
unknown amount. 
intravenous 
(IV) preload of 
15ml/kg of 
Lactated 
Ringer’s 
Solution (LR) 
was given 
Age 18-years or 
older, weight 
90Kg or less, 
height 152cm or 
greater, ASA I 
or II, and term 
singleton 
pregnancy. 
The incidence 
of 
hypotension 
was halved in 
the E+P 
(37%) group 
when 
compared 
with the E 
(75%) group 
(P=0.02). 
SBP values 
after onset of 
spinal 
anesthesia 
were not 
significantly 
different 
Spinal 
anesthesia 
was 
performed at 
the L2-L3 or 
L3-L4 
interspace 
with the 
patient 
sitting, using 
a 9 cm 25 
gauge 
whitacre 
spinal 
needle. 
11mg of 
hyperbaric 
0.5% 
Bupivacaine, 
Umbilical 
venous and 
arterial pH 
values were 
significantly 
higher in 
the E+P 
group (7.24) 
than in the 
E group 
(7.19) 
(P=0.05).  
 
The 
incidence of 
arterial pH 
<7.20 was 
31% higher 
in the E+P 
Apgar 
scores at 
1 and 5 
min were 
similar in 
both 
groups 
(p=0.7) 
and were 
never less 
than 7. 
 Low 
venous and 
arterial pH 
values 
were 
associated 
only with 
the E group 
assignment 
and spinal 
anesthesia 
to delivery 
times 
longer than 
33 min. 
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between the 
two groups. 
2.5 mcg 
Sufentanil 
and 0.1 mg 
morphine 
was injected 
through the 
spinal 
needle. 
group and 
63% in the 
E group 
(P=0.09). 
Moslem
i, F., & 
Rasooli, 
S. 
(2015). 
Not reported Prior to spinal 
anesthesia all 
participants 
received a 500 
ml crystalloid 
bolus. 
healthy 
pregnant 
women with 
gestational age 
of 36 weeks or 
higher and non-
emergency c-
section 
SBP after 
anesthesia 
every 2 and 
every 5 
minutes were 
different 
(P>0.050) in 
the Ph and P 
groups. 
participants 
then 
received 
spinal 
anesthesia 
by an 
anesthesiolo
gist in the 
sitting 
position 
from L4/5 or 
L3/4 inter-
vertebral 
spaces with 
2.5 ml of 
Bupivacaine 
0.5% 
(12.5mg) 
and 2.5 mcg 
of 
Sufentanil. 
UA 
(umbilical 
artery) 
blood gas 
analysis 
showed a 
significant 
difference 
in pH 
between the 
Ph and P 
groups. 2 
neonates in 
the Ph 
group, 7 in 
the E group 
and 5 in the 
P group had 
acidosis. 
Acidosis 
was 
significantly 
lower in 
phenylephri
ne group 
(P=0.043) 
There 
was no 
significan
t 
difference 
in the 1 
min 
APGAR 
scores 
between 
all of the 
groups. 
There 
was a 
significan
t 
difference 
in the 5 
min 
APGAR 
scores  
was 
shown to 
be better 
with 
group Ph 
and E 
than with 
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group P 
(P=0.002) 
 
